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ABSTRACT OF THE DISSERTATION 
 
 
HIV RISK BEHAVIORS, PREVIOUS HIV TESTING AND POSITIVITY AMONG 
HISPANIC WOMEN TESTED FOR HIV IN FLORIDA, 2012 
 
by 
Janelle Taveras 
Florida International University, 2017 
Miami, Florida 
Professor Mary Jo Trepka, Major Professor 
 
 
The prevalence of female adults and adolescents living with diagnosed HIV 
infection continues to rise. Latina women in the United States (US) are not only 
disproportionately affected by human immunodeficiency virus (HIV) infection, but also 
underutilize HIV prevention services, such as HIV testing. Data are limited on the 
differences in HIV risk among Latinas by country of birth, and opportunities still exist to 
prevent transmission of HIV and reduce HIV-related disparities. This dissertation 
describes the risk behaviors, testing behaviors, and test results among women tested for 
HIV at public sites in Florida. Additionally, it compares these characteristics by HIV 
testing site type among pregnant women. Multivariable logistic regression was used to 
estimate the adjusted odds ratios (AOR) and associated 95% confidence intervals for the 
outcome variables of risk behaviors, previous testing, and positive HIV test results. 
Of the total 209,954 records, 184,037 were from women not currently pregnant, 
of which 87,569 (45.6%) were among non-Hispanic Blacks (NHBs), 47,926 (26.0%) 
vii  
non-Hispanic Whites (NHWs), and 41,117 (22.3%) Latinas. Women who reported 
previous HIV testing had decreased odds of being Latina compared to NHW women 
(AOR 0.90; 95% confidence interval [CI] 0.87, 0.94), and testing event results indicate 
that foreign-born Latina women were significantly less likely to report partner risk (AOR 
0.42; 95% CI: 0.40-0.54) than US-born Latina women. Of the 24,863 records of pregnant 
women, 10,199 (41.1%) were among Latinas, 6,796 (27.4%) were among NHB, and 
6,631 (26.7%) were among NHW. The testing records indicated that Latina and NHB 
women had decreased odds of reporting partner risk than NHW women (Latina: AOR 
0.20; 95% CI: 0.14-0.28; and NHB: AOR 0.14; 95% CI: 0.10-0.21), and records of 
women tested in prisons/jails had higher odds of reporting previous HIV testing 
compared to prenatal care sites (AOR 1.86; 95% CI: 1.03-3.39). 
Reported risk behaviors varied by race/ethnicity and Latina country of origin. 
Knowledge of these differences can enhance current testing and prevention strategies for 
women, and aid in targeting HIV prevention messaging, program decision-making, and 
allocation of resources, corresponding to the central approach of High Impact Prevention 
and the National HIV/AIDS Strategy. 
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INTRODUCTION 
 
 
The demographics of the HIV epidemic in the United States have changed over 
the years; HIV infection now affects more women and members of ethnic/racial minority 
populations than in previous years (Institute of Medicine, 2001; Centers for Disease 
Control and Prevention [CDC], 2016a). Although Latinos make up approximately 17% of 
the US population, they make up about 24% of all newly diagnosed HIV infections 
(United States Census Bureau, 2015; CDC, 2016a). In 2014, the incidence of HIV among 
Latino men was more than triple the rate among non-Hispanic white (NHW) men (37.4 
cases per 100,000 vs. 10.8 cases per 100,000), and rates among Latina women and NHW 
women demonstrate a similar disparity (5.3 cases per 100,000 vs. 1.6 cases per 100,000) 
(CDC, 2016a). Given these incidence rates, it is particularly important that HIV risk and 
testing behaviors among this population be examined. 
 
Another notable change in the US HIV epidemic is the decline in the number of 
perinatal infections (188 in 2010 and 86 in 2015). Nevertheless, the prevalence of female 
adults and adolescents living with diagnosed HIV infection continues to rise (163.8 per 
100,000 in 2010 and 171.0 per 100,000 in 2015), and it is estimated that 8,500 women 
living with HIV give birth every year (CDC, 2016b). As there continue to be HIV- 
positive women of childbearing age, it is important to continue robust HIV prevention 
efforts for this population (Nesheim et al., 2012). Evaluation of HIV testing records 
among pregnant and non-pregnant women can help to identify disparities in HIV risk and 
testing behaviors in order to better inform current HIV prevention strategies. 
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Latinos living in the US are culturally diverse, and differ in national origin, mode 
of HIV transmission, HIV risk behaviors, risk perception, use of prevention services, and 
timeliness of HIV testing, which have been found to vary by race/ethnicity and country of 
birth (CDC, 2007; CDC, 2013a; Espinosa et al., 2007). Many factors, including 
acculturation, culture, and socioeconomic status may explain these disparities in 
incidence rates (Marin, 2003; CDC, 2008; Gonzalez-Guarda et al., 2011). In addition, 
studies have identified differences concerning risk behaviors, between foreign-born 
Latinos (FBL) and US-born Latinos (USBL), but have limited information for women 
from diverse Latin countries of origin (Kaiser Family Foundation, 2006; CDC, 2007, 
Grieco, 2009; CDC, 2013a, Chandra, Billioux, Copen & Sionean, 2012; Castillo- 
Mancilla et al., 2012, Sionean, 2012; Rios-Ellis et al., 2008,  Dixon, Antoni, Peters & 
Saul, 2001; Dixon, Peters & Saul, 2003; Zambrana, Cornelius, Boykin & Lopez, 2004; 
Moreno, Morrill & El-Bassel, 2011). Due to limitations of previous studies, there is also a 
need to study risk factors and HIV testing behaviors among Latinas by taking into 
account country of birth and utilizing a more diverse sample of Latinas living in the US. 
The Centers for Disease Control and Prevention (CDC) recommends that all 
individuals, aged 13–64 years of age, be screened on an “opt out” basis (consent is 
inferred unless the patient declines testing) for HIV infection at all health care settings as 
part of routine medical care. Persons at high-risk for HIV infection should be screened at 
least once annually (CDC, 2006). Both the CDC’s “Guide for HIV Testing in Nonclinical 
Settings” and “Revised Guidelines for HIV Counseling, Testing, and Referral” also 
emphasize the importance of early knowledge of HIV status and increasing the 
accessibility and availability of HIV testing services (CDC, 2016c; CDC, 2001). HIV 
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testing is the central step in both the HIV prevention continuum and HIV care continuum, 
which collectively create a framework for monitoring and evaluating HIV program 
performance (The White House Office of the Press Secretary, 2013; McNairy & El-Sadr, 
2014). HIV testing also creates opportunities to link HIV-positive and HIV-negative 
people to appropriate care and prevention services. For an HIV-positive person, this 
means linkage to medical care, appropriate antiretroviral therapy (ARV), and prevention 
services leading to a suppressed viral load and lower probability of transmitting HIV to 
sex partners (CDC, 2001; CDC, 2011; Hall, Walker, Shah & Belle, 2012; Marks et al., 
2005). Furthermore, recommendations emphasize routine HIV screening as part of 
prenatal care (CDC, 2001b). 
 
Despite the CDC report that HIV testing rates have increased from 2000 to 2010 
(CDC, 2013b), the National HIV Behavioral Surveillance data indicate that only 60.7% 
of Latinos report having ever been tested for HIV compared to 70.2% among NHWs and 
80% of NHBs (CDC, 2015). Additionally, Latinos with HIV infection are more likely to 
be tested late in their HIV infection compared with NHWs (CDC, 2013c; CDC, 2003; 
Chen, Gallant & Page, 2012; Sheehan, Trepka & Dillion, 2014). Furthermore, even with 
evidence that regimens of antiretroviral therapy have significantly reduced rates of 
mother-to-child transmission of HIV, studies demonstrate that opportunities to prevent 
transmission still exist to enhance HIV testing, care and treatment of HIV-infected 
pregnant women, and understanding birth trends and patterns of care among these women 
(Trepka et al., 2017; Moyer, 2013; Sansom et al., 2007; McKenna and Hu, 2007; 
Nesheim et al., 2012). Improved testing strategies and early identification of HIV 
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infection among women can improve HIV-related outcomes along the HIV care 
continuum including linkage to care, retention in care, and viral load suppression and 
further reduce mother-to-child transmission of HIV (CDC, 2013c; Gant et al., 2014, 
Nesheim et al. 2012). 
 
The use of a large data set inclusive of a diverse sample of Latinas representing 
all Latin countries of origin was not found in previous literature. This study utilized a 
large state-wide data set that encompassed a diverse sample of Latinas, to identify HIV 
risk differences by race/ethnicity, US-born versus foreign-born status among Latinas, and 
by Latina country of birth. The overall objective of this study was to characterize the risk 
behaviors, testing behaviors, and HIV test results among all women who tested for HIV 
at public sites in Florida, a state with a diverse Latina community, to compare these 
characteristics by HIV testing site type for pregnant women and to possibly understand 
motivations for receipt of these services. The objective was accomplished through three 
separate studies. The first study aimed to differentiate HIV risk behaviors among women 
tested at publicly funded HIV testing sites in Florida, and to compare reported risk 
behaviors, including personal and partner risk, among women by race/ethnicity, foreign- 
birth status (nativity) among Latinas, and country of birth among Latinas. The second 
study aimed to compare HIV testing behaviors and outcomes between Latina women and 
women in other racial/ethnic groups tested at publicly funded sites in Florida, in order to 
determine if HIV testing activities are reaching the populations disproportionately 
affected by HIV. The third and final study aimed to identify reported HIV risk behaviors, 
testing behaviors, and demographics of pregnant women tested at publicly funded sites in 
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Florida, and to compare these characteristics by HIV testing site type. In addition, the 
outcomes of this study can guide practices for regular monitoring and evaluation of HIV 
prevention, testing, and care services provided to women in the State of Florida. 
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Abstract 
 
 
Objective: Latina women in the United States (US) are disproportionately affected by 
human immunodeficiency virus (HIV) infection.  Data are limited on the risk differences 
in HIV among Latinas by country of birth.  This paper describes the risk behaviors 
among Latina women tested for HIV at public sites in Florida.  Methods: Multivariate 
logistic regression was used to assess the demographic characteristics associated with the 
report of specific risk behaviors.  Results: Results indicate that foreign-born Latina 
women were significantly less likely to report partner risk (adjusted odds ratio [AOR]: 
0.46; 95% confidence interval [CI]: 0.40-0.54) than US-born Latina women. 
Conclusion: Reported risk behaviors varied by race/ethnicity, US-born versus foreign- 
born status, and by Latina country of origin. Knowledge of these differences can aid in 
targeting HIV prevention messaging, program decision-making, and allocation of 
resources, corresponding to the central approach of High Impact Prevention (HIP) and 
the National HIV/AIDS Strategy (NHAS). 
 
 
 
KEYWORDS: Latinas, Foreign-born, HIV, Risk behaviors, High Impact Prevention 
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Introduction 
 
The demographics of the HIV epidemic in the United States have changed over 
the years; HIV infection now affects more women and members of ethnic/racial minority 
populations than ever before (Institute of Medicine, 2001; CDC, 2012). Although 
Latinos make up to 16% of the US population, they account for 21% of all new HIV 
infections (CDC, 2013a).  The incidence of HIV among Latino men is more than double 
the rate among non-Hispanic white (NHW) men (45.5 cases per 100,000 vs. 14.2 cases 
per 100,000), and the HIV incidence among Latina women is three-fold higher than 
NHW women (8.0 cases per 100,000 vs. 2.6 cases per 100,000) (CDC, 2012). 
 
Many factors, including acculturation, culture, and socioeconomic status may 
explain these disparities in incidence rates (Marin, 2003; CDC, 2008; Gonzalez-Guarda  
et al., 2011).  When examining HIV risk behaviors, in relation to race/ethnicity, 
ambiguous or conflicting results have been reported.   A study published by Brown et al., 
in 2007, examined recent (12-month recall) high-risk behaviors among US women aged 
18 to 49 years and reported more risk behaviors among non-Hispanic black (NHB) and 
Latina women compared to NHW women, although none of these differences was 
significant (Brown, Taylor, Mulatu & Scott, 2007). Latina women, however, reported 
significantly fewer HIV-related sexual risk behaviors but significantly more HIV risk- 
related drug behaviors (these include illicit drug injection, crack cocaine use or crystal 
meth use in the past year) than NHB women (Chandra, Billioux, Copen & Sionean, 
2012). Compared to NHW women, Latina women are less likely to become infected with 
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HIV through injection drug use, although modes of transmission have been shown to vary 
by country of birth (Kaiser Family Foundation, 2006; CDC, 2007). 
 
Forty percent of US Latinos are foreign-born, and more than half of all HIV cases 
among Latinas, for which country of birth data were available, are among Latinas born 
outside the continental US, primarily from Cuba, Puerto Rico, and Central America 
(Grieco, 2009; CDC, 2013b). Though these data suggest a disproportionate impact on 
foreign-born Latinas, some studies suggest that foreign-born Latinas (FBL) have fewer 
risk behaviors than US-born Latinas (USBL) (Chandra, Billioux, Copen & Sionean, 
2012; Castillo-Mancilla et al., 2012). Among Latina women, ages 15 – 44 years, USBL 
reported significantly higher percentages of five or more opposite-sex partners, treatment 
for STDs, and HIV risk-related behaviors (Chandra, Billioux, Copen & Sionean, 2012; 
Rios-Ellis et al., 2008). Also much of the published data on Latinas and HIV risk 
behaviors focuses primarily on women of Mexican and Puerto Rican descent (Dixon, 
Antoni, Peters & Saul, 2001; Dixon, Peters & Saul, 2003; Zambrana, Cornelius, Boykin 
& Lopez, 2004; Moreno, Morrill & El-Bassel, 2011). These studies have identified 
differences concerning risk behaviors, between FBL and USBL, but have been limited 
and not inclusive of all Latin countries of origin. 
Latinos living in the US are culturally diverse, and differ in national origin, mode 
of HIV transmission, HIV behavioral risk factors, perception of risk, use of prevention 
services, and timeliness of HIV testing which have been found to vary by race/ethnicity 
and country of birth (CDC, 2007; CDC, 2013; Espinosa et al., 2007). Due to limitations 
of previous studies, there is a need to study risk factors and HIV testing behaviors among 
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Latinas by taking into account country of birth and utilizing a more representative sample 
of Latinas living in the US. 
The objectives of this study were to characterize HIV risk behaviors among 
women tested at publicly funded HIV testing sites in Florida, a state with a diverse Latina 
community, and to compare reported risk behaviors, including personal and partner risk, 
among women by race/ethnicity and by foreign-birth status among Latinas, and by 
country of birth among Latinas. 
Methods 
Study design and population 
 
This was a cross-sectional study using de-identified data from the Florida HIV 
Counseling and Testing database, which included demographic and risk behavior 
information from all records of women tested for HIV in publicly-funded HIV counseling 
and testing sites in Florida. These data were recorded on the Department of Health 1628 
Testing and Counseling Forms and completed by trained counselors, who collect 
demographic and risk behavior information from persons voluntarily testing for HIV. 
The variables captured included self-reported risk behaviors during the 12 months prior 
to testing, country of birth, race, ethnicity, gender, previous HIV testing, and current 
testing site. This information was sent to the Florida Department of Health Counseling, 
Testing and Linkage data team, where it was entered into a database. The dataset for the 
current study included HIV publicly-funded testing events for women, 13 years of age 
and older, testing for HIV, in the state of Florida during 2012. 
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Inclusion Criteria 
 
 
A total of 184,037 testing event records from women were included in the 
analysis. Because records were de-identified, it is possible that some women were tested 
more than once in the given year and thus may be represented more than once in the 
dataset. However, it was not possible to identify any duplicate records. For ease of 
reading in this manuscript, results are reported using the terminology of “women” as 
opposed to “testing events”. Of the total women, 41,117 were Latinas; 47,926 NHW; 
87,569 NHB; 1,753 belonged to other racial/ethnic group and 5,672 had missing 
racial/ethnic information. Women that responded “yes” to current pregnancy (24,836) 
were excluded from the analysis because these HIV tests may have likely been driven by 
routine testing as opposed to testing because of perceived risk of HIV infection. Records 
from transgender individuals were excluded from the sample because of small numbers 
(59 Latina, 57 NHW, 120 NHB, 3 other race/ethnicity, and 3 missing race/ethnicity). Sex 
with only women in the past 12 months was not an HIV risk factor analyzed in this study, 
since the majority of HIV transmission among women is through heterosexual exposure 
and case reports of female-to-female transmission are rare (CDC, 2012). 
 
Classification of risk: variables used in this study 
 
Great diversity exists in approaches that have been used to measure the degree of 
HIV risks (Brown et al., 2007; Wallace et al., 2011; Blackstock et al., 2010; Bond, Lauby 
& Batson, 2005; Djokic et al., 2009; Renzi et al., 2004; Vargo et al., 2004; Wiggers et al., 
2003; Whyte, 2005; Catania et al., 1995; Bishop, Kok & Chan, 1998; Fitterling et al., 
1993; Pathela et al., 2006; Chirgwin et al., 1991; Hong et al., 2011; Susser, Desvarieux & 
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Wittkowski, 1998). A study published by Hong and colleagues in 2010, utilized an index 
of risk by exposure category: partner risk exposure versus personal risk exposure, which 
was used as a model for risk definition in this study. Personal risk was defined as any 
factor which would place an individual at-risk for HIV based on their own risk behaviors 
or activities. Partner risk was defined as having vaginal or anal sex with a partner who 
had an increased risk of HIV (Table 1). In addition, each individual risk behavior was 
analyzed. The questions included vaginal/anal sex with a man and did not separate the 
two sex acts. Therefore, it was not possible to analyze vaginal sex and anal sex 
separately. 
Statistical analysis 
 
 
Descriptive statistics and other preliminary analyses were first performed 
considering age, race/ethnicity, and previous HIV testing and risk factors listed in Table 
1. All of the variables were categorical except age, which was collected in years and then 
recoded into categories.  Bivariate analyses were performed to determine if there were 
differences in age, HIV risk factors, and testing by race/ethnicity. Further analysis was 
restricted to records of Latina women to compare records of Latinas born in the 
continental US (hereafter referred to as US-born) vs. records from Latinas born in other 
countries or Puerto Rico (hereafter referred to as foreign born). The bivariate analyses 
were repeated among foreign-born Latinas to compare risk factors by country of birth. 
 
Controlling for age, two sets of multivariate analysis were conducted. The first set 
had ‘personal risk behavior’ as the dependent variable. The second set had ‘partner risk 
behavior’ as the dependent variable. For each set, the groups were compared three 
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different ways to calculate adjusted odds ratios (AOR) and 95% confidence intervals 
(CI) to examine differences in risk behaviors among women publicly tested for HIV in 
Florida: by 1) race/ethnicity; 2) FBL vs. USBL; and 3) Latina country of birth. Previous 
HIV testing history was also included as an independent variable. Clustering effects of 
testing site were handled through a random intercept using SAS Proc Glimmix. SAS 
software, version 9.3 (SAS Institute, Cary, NC 2002) was used to conduct all analyses. 
The Florida Department of Health and Florida International University’s Institutional 
Review Boards (IRB) deemed this study non-human subjects research and exempt from 
IRB review. 
Results 
 
Sample characteristics 
 
Of the 184,037 women included in these analyses, 47.6% were NHB, 26.0% 
NHW, 22.3% Latina, 3.1% had no recorded race/ethnicity (‘Missing’), and 1.0% 
belonged to other race/ethnic group (‘Other’) (Table 2). The largest proportion of women 
(44.1%) were 20 – 29 years of age followed by 30 – 39 years (21.5%). Most participants 
(92.6%) reported personal risk in the prior 12 months while only 5.0% reported partner 
risk in the prior 12 months. The most frequently reported risk was vaginal/anal sex with 
a male (89.4%) followed by STD diagnosis (7.4%), sex for drugs/money/other items 
(3.6%), vaginal/anal sex with an IDU (3.1%), injection drug use (3.1%), and vaginal/anal 
sex with an HIV positive person (1.1%). 
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Race/ethnicity among HIV testing women 
 
Significant differences between racial/ethnic groups with respect to reported 
risks were identified in the bivariate analyses. Personal risk was more frequently 
reported by NHW women than Latinas and NHB women (92.0% vs. 90.2% and 88.6% 
respectively; p<0.0001). Latina women reported less partner risk than NHW women 
(3.1% vs. 12.3%; p <0.0001) but reported more partner risk than NHB women (3.1% vs. 
1.9%; p<0.0001). Compared to NHW women, all risk factors were less frequently 
reported by Latina women (p<0.0001). However, compared with NHB women, Latina 
women more frequently reported vaginal/anal sex with a male (89.9% vs. 88.3%; 
p<0.0001), injection drug use (1.4% vs. 0.4%; p <0.0001), vaginal/anal sex with an IDU 
(1.5% vs. 0.4%; p<0.0001), and vaginal/anal sex with an MSM (0.8% vs. 0.7%; p= 
0.0350). Latina women tended to be older with greater proportions of those being 40 – 
49 years of age (14.7%) and 50 years of age and over (9.5%), as compared with NHW 
and NHB women (Table 2). In multivariate analysis, when controlling for age, Latina 
and NHB women were less likely to report both partner and personal risk than NHW 
women (Latina: AOR 0.38, 95% CI: 0.35-0.41; AOR 0.85, 95% CI: 0.80-0.89 and NHB: 
AOR 0.18, 95% CI: 0.17-0.20; AOR 0.71, 95% CI: 0.68-0.75 respectively) (Table 3). 
HIV testing among Latina women by US-born and foreign-born status 
 
 
Foreign-born Latinas tended to be older than US-born Latinas (e.g. among 40-49 
year olds 18.3% vs. 10.0% and among 50 and older 12.9% vs. 4.6%) with a mean age of 
35 versus 29 years for USBL (Table 4). Univariate analysis showed no significant 
difference between the report of personal risk among FBL and USBL (89.9% vs. 89.3%; 
p=0.0882). However, Latina women missing a country of birth more frequently reported
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personal risk compared to FBL (92.8% vs. 89.9%; p <0.0001). Partner risk was more 
frequently reported by USBL than FBL (6.6% vs. 1.7%; p <0.0001) and more frequently 
reported by women missing a country of birth than FBL (3.4% vs. 1.7%; p <0.0001). All 
risk factors, with the exception of sex (vaginal or anal) with a male, were reported more 
frequently by USBL than FBL (Table 4). In the multivariate analysis, controlling for age, 
comparing records of USBL, FBL were 54% less likely to report partner risk (AOR: 0.46; 
95% CI: 0.40-0.54) but not significantly less likely to report personal risk (AOR: 0.98; 
95% CI: 0.89-1.08) (Table 3). 
 
 HIV testing among Latina women by country of birth 
 
 
Latina women reported the following countries of birth: US (22.7%), Mexico 
(15.9%), Cuba (9.6%), Colombia (5.5%), Honduras (4.7%), Guatemala (4.4%), Puerto 
Rico (4.4%), Nicaragua (2.6%), Dominican Republic (2.6%), other South American 
(OSA) countries (2.7%), El Salvador (2.2%), Peru (2.2%), Venezuela (1.9%), Brazil 
(1.0%), and other Central American (OCA) countries (0.9%) (Table 5). The countries of 
birth with the highest proportions of women 50 years and over were Colombia, Cuba, 
Nicaragua and Dominican Republic (26%, 20%, 18% and 18% respectively) (Table 5). In 
the univariate analysis, USBL tended to be younger; 17.3% were 13-19 years of age and 
50.1% were 20-29 years.  Personal risk was most frequently reported among women born 
in El Salvador (93.7%) and Mexico (93.6%), while partner risk was more frequently 
reported by women born in the US (6.6%) and Puerto Rico (5.9%). Women born in 
Mexico and El Salvador equally reported the highest percentage (93.5% each) of vaginal 
or anal sex with a male.  Exchanging anal, vaginal or oral sex for drugs, money or other 
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items was most frequently reported by USBL (4.4%). USBL were more likely to report 
previous STD diagnosis (7.8%), sex with an IDU (4.0%), and injection drug use (3.8%). 
Vaginal/anal sex with an HIV-positive person was most frequently reported by Puerto 
Rican born women (2.6%). Vaginal/anal sex with an MSM was reported most frequently 
by women born in Brazil (2.0%). Most FBL reported less partner risk and personal risk 
compared to USBL.  However, results varied by country of birth and by specific risk 
subgroup.  FBL born in in Mexico, El Salvador, Guatemala, Honduras, Brazil, and other 
Central America reported more personal risk compared to USBL (Table 5). However, 
after controlling for age, in the multivariate analysis, there was only one significant 
difference, namely between Latinas born in Mexico and USBL (AOR: 1.31; 95% CI: 
1.13-1.52) (Table 3). 
 
Discussion 
 
 
Among all women tested for HIV in Florida, the majority reported some form of 
personal risk, most commonly vaginal/anal sex with a man, while partner risk was less 
frequently reported.  Latinos living in the US represent a diverse set of nationalities, 
ethnicities, ages, educational attainment, culture and acculturation levels.  However, 
Latinos are often studied as a homogeneous group (Espinosa et al., 2007; Kinsler et al., 
2009; Vega et al., 2015).  Results indicate differences in reported risk behaviors by 
race/ethnicity, and among Latinas by country of birth, especially when examining 
specific reported risk behaviors.  Partner risk was less frequently reported than personal 
risk for all women testing for HIV in Florida even though most HIV-infected women in 
Florida reported exposure through high risk heterosexual contact (Florida Department of 
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Health, 2013). However, many women are unaware of their partner’s risk behaviors or 
may have misconceptions about partner risk (Cianelli et al., 2010; Abel & Chambers, 
2004; Essien, Meshack & Ross, 2002).  It is likely that partner risk is more prevalent than 
what these findings report. 
 
Latina and NHB women reported less personal and partner risk than NHW 
women although risk subgroups did vary.  This finding differs from prior literature where 
it was found that Latina and NHB women had higher risk behaviors than NHW (Brown  
et al., 2007; Chandra et al., 2012). These differences could be explained by varying 
definitions of risk including the capturing of recent versus lifetime risks (Brown et al., 
2007; Chandra et al., 2012).  It is important to define risks similarly to improve the ability 
to make comparisons between samples.  Latina women were also seeking HIV testing 
services at a later age than NHW and NHB women. This could mean that HIV testing 
among Latinas is related to acculturation, defined as 5 or more years living in the United 
States, which may explain a delay in HIV testing behaviors and the older age of Latinas 
at the time of HIV testing (Kinsler et al., 2009). 
 
Results of comparisons among US-born and foreign-born Latinas also provided 
more insights into the prevalence of certain risk behaviors.  USBL were more likely than 
FBL to report the most risk behaviors, which agrees with previous literature (Chandra et 
al., 2012; Castillo-Mancilla et al., 2012; Rios-Ellis et al., 2008).  However, reported risk 
factors vary depending on country of birth (CDC, 2007; Espinoza et al., 2007).  There 
may be a greater acceptance of FBL to report less stigmatizing risks, such as sex with a 
male, or an overall misunderstanding of risk among this group of women (Essien, 
20   
Meshack & Ross, 2002).  Significant differences by country of birth were identified when 
further examining partner risk subgroups. Women born in Brazil were most likely to 
report vaginal or anal sex with an MSM, and Puerto Rican-born women were the most 
likely to report vaginal or anal sex with an IDU.  Previous literature has also suggested 
higher MSM activity in South America and Cuba, IDU in Puerto Rico, and high-risk 
heterosexual contact in Dominican Republic (Kaiser Family Foundation, 2006; CDC, 
2007; Kang et al., 2009).  These variations in risk factors by country of birth may be 
rooted in an increased awareness of partner’s behavior by Latina women born in certain 
countries or increased prevalence of risk behaviors in these countries (Kinsler et al., 
2009; Montealegre et al., 2012; Gimenez-Garcia, 2013). 
 
This study was limited due to the use of self-report of HIV risk. Most HIV- 
positive women have been infected through their partner’s risk such as sex with an MSM 
or IDU, but many are unaware of their partners’ risk behavior (Abel & Chambers, 2004). 
Not all women reported recent risk behaviors which may indicate delays in HIV testing 
after risk exposure, a lack of awareness of partners’ HIV risk, and possible under- 
reporting of HIV risk, especially partner risk (Essien, Meshack & Ross, 2002). Under- 
reporting may be due to stigma, feelings of shame, guilt, denial, or not being cognizant of 
partner’s engagement in certain risk behaviors and/or partners’ HIV status (Gimenez- 
Garcia, 2013). 
 
Another limitation was that the dataset only included information on HIV testing 
conducted at publicly funded HIV testing sites. There may be differences in the women 
testing in private versus public HIV testing locations because public HIV testing requires 
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no insurance. Variables such as acculturation, condom-protected sex acts, or the use of 
other forms of HIV prevention such as pre-exposure prophylaxis (PrEP) were also not 
captured. Obtaining proxy information for acculturation, such as years living in the US 
and preferred language, and additional prevention information may be useful in assessing 
HIV risk behaviors among Latinas (Kang et al., 2009). Although undocumented status is 
not recorded at testing sites, any form of identification could be used for voluntary HIV 
testing, which increases the likelihood that FBL who were not legally in the United States 
were included in the data. 
 
Country of birth was missing for a notable number of records of Latina women. 
Compared to FBL, those with missing country of birth had reported significantly more 
risks overall for all risk categories except vaginal or anal sex with a male.  This may 
suggest that this group of Latina women missing a country of birth were not foreign born 
or they felt at more liberty to report risk behaviors by not revealing personal identifying 
information.  However, there is no way to confirm this with the available data set. The 
HIV testing data set provided de-identified records of HIV testing. Although it may be 
possible that some women were tested more than once in the given year, and thus may be 
represented more than once in the dataset, it was not possible to identify any duplicate 
records. 
 
Conclusions 
 
 
The results of this study add important information to improve HIV prevention 
and care among Latinos in Florida and assist in the three primary goals of the National 
HIV/AIDS Strategy (NHAS): 1) reducing the number of people who become infected 
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with HIV; 2) increasing access to care and improving health outcomes for people living 
with HIV; and 3) reducing HIV-related health disparities (Office of National AIDS 
Policy, 2010).  The CDC’s High Impact Prevention (HIP) response to the NHAS, which 
targets populations at greatest risk and geographic areas hardest hit by HIV, and includes 
Latinos in the state of Florida (CDC, 2011).  The importance of studying and increasing 
testing among Latinos as a HIP strategy was also highlighted by the Florida Latino AIDS 
Advisory group in a document titled “Test and Treat Latino HIV/AIDS in Florida” 
(Castillo-Mancilla et al., 2012; Florida Department of Health, 2011). Current prevention 
strategies for women do not consider cultural differences between Latinas from different 
countries of origin (Zambrana et al., 2004; CDC, 2011; Rios-Ellis et al., 2008). 
Examining Latinas by their country of birth, in addition to comparing US-born and 
foreign-born Latinas, provided a greater understanding of risk differences that were 
associated with the women of specific Latin countries.  This new understanding can assist 
in tailoring effective prevention strategies for this diverse population of women. The 
strength of this study is that it provides proportion estimates of risk behaviors by country 
of birth for a diverse group of Latina women publicly testing for HIV.  Diversity in the 
reported risks suggests that awareness of HIV risk, as much as the presence of the 
behavioral risk itself, may be influenced by additional factors including culture and 
acculturation.  Measures for acculturation, such as preferred language and/or years living 
in the United States, in addition to prevention data (i.e. consistent condom use and use of 
PrEP) should be collected at publicly funded HIV testing sites as well. 
 
HIV testing messages and services have mostly been targeted to MSM and black 
communities and thus may be less effective among Latinos.  However, there are limited 
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data on cultural variations in knowledge, beliefs and behaviors specific to Latinos 
(Kinsler et al., 2009; Vega et al., 2015; Gimenez-Garcia et al., 2013).  Since a notable 
number of Latinas were missing a country of birth (16.2%), emphasis should also be 
made in capturing more complete and accurate data on the DH 1628 TCF. Understanding 
the cultural difference of reported risks behaviors by race/ethnicity and Latino country of 
birth, especially around the topics of partner risk and communication, is important to 
guide prevention efforts and create effective HIV testing messages (Montealegre et al., 
2012; Gimenez-Garcia et al., 2013; Rios-Ellis et al., 2008). A greater understanding of 
partner risk can increase HIV susceptibility and HIV testing behaviors among Latinas and 
may be a critical component to improve the reporting of risk information and increase the 
effectiveness of tailored, large-scale, risk reduction counseling for Latinas (Cianelli et al., 
2010). Therefore, increasing partner communication is a topic that should be addressed 
by HIV testing messages for Latinas in Florida. Future studies should further examine 
the concept of partner behaviors as it relates to culture and HIV risk among Latinas. 
 
Lastly, increased HIV testing in private medical settings is expected due to the 
promotion of routine HIV testing through national and state initiatives (Office of National 
AIDS Policy, 2010).   The collection of risk and prevention behavior data should be 
incorporated as part of all HIV testing, regardless of funding source and routinely 
analyzed to enhance HIV programing and evaluation. 
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Tables and Figures 
 
 
Table 1. HIV risk categories 
 
Personal risk exposure categories Risk based on partner exposure categories 
Sex (vaginal/anal) with a male Sex (vaginal/anal) with HIV positive person 
Sex for drugs/money/other items (anal, vaginal or 
oral) 
Sex (vaginal/anal) with an IDU 
STD diagnosis Sex (vaginal/anal) with a MSM 
Injection drug use 
STD = sexually transmitted disease, HIV = human immunodeficiency virus, IDU = injection drug user, MSM 
= man that has sex with men 
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Table 2. HIV risk behaviors, previous HIV testing and demographics by race/ethnicity for women not currently pregnant 
 
Race/ethnicity 
 
Total 
 
Latina 
n (%) 
 
NHW 
n (%) 
 
NHB 
n (%) 
 
Other 
n (%) 
 
Missing 
n (%) 
 
Latina 
vs. NHW 
p-valuea 
 
Latina vs. 
NHB 
p-valuea 
Total 184,037 n = 41,117 n = 47,926 n = 87,569 n = 1,753 n = 5,672   
Mean Age (years) 30.5 32.1 30.3 30.0 30.9 30.1   
Age group (n)       <0.0001 <0.0001 
13-19 24,522 
(13.3) 
4,379 
(10.7) 
6,974 
(14.6) 
12,084 
(13.8) 
202 
(11.5) 
883 
(15.6) 
  
20-29 81,231 
(44.1) 
16,042 
(39.0) 
21,103 
(44.0) 
40,811 
(46.6) 
791 
(45.1) 
2,484 
(43.8) 
  
30-39 39,605 
(21.5) 
10,748 
(26.1) 
9,698 
(20.2) 
17,590 
(20.1) 
379 
(21.6) 
1,190 
(21.0) 
  
40-49 23,158 
(11.5) 
6,038 
(14.7) 
6,182 
(12.9) 
10,048 
(11.5) 
234 
(13.4) 
647 
(11.4) 
  
50 and over 15,530 
(8.4) 
3,910 
(9.5) 
3,969 
(8.3) 
7,036 
(8.0) 
147 
(8.4) 
468 
(8.3) 
  
 30 
 
 
 
 
 
 
 
Any personal risk 
 
 
165,194 
 
 
37,088 
 
 
44,174 
 
 
77,579 
 
 
1,539 
 
 
4,814 
 
 
<0.0001 
 
 
<0.0001 
 (89.8) (90.2) (92.2) (88.6) (87.8) (84.9)   
Sex (vaginal or anal) with a male 164,486 36,982 43,848 77,332 1,532 4,792 <0.0001 <0.0001 
 (89.4) (89.9) (91.5) (88.3) (87.4) (84.5)   
Sex for drugs/money/other items 6,579 745 3,775 1,883 38 138 <0.0001 <0.0001 
(anal, vaginal or oral) (3.6) (1.8) (7.9) (2.2) (2.2) (2.4)   
STD diagnosis 13,616 1,971 3,994 7,066 108 477 <0.0001 <0.0001 
 (7.4) (4.8) (8.3) (8.1) (6.2) (8.4)   
Injection drug use 5,789 566 4,751 305 44 123 <0.0001 <0.0001 
 (3.1) (1.4) (9.9) (0.4) (2.5) (2.2)   
Any partner risk 9,130 1,276 5,881 1,691 77 205 <0.0001 <0.0001 
 (5.0) (3.1) (12.3) (1.9) (4.4) (3.6)   
Sex (vaginal or anal) with HIV- 2,101 434 707 899 14 47 <0.0001 0.6330 
positive person (1.1) (1.1) (1.5) (1.0) (0.8) (0.8)   
Sex (vaginal or anal) with an 5,795 635 4,669 311 53 127 <0.0001 <0.0001 
IDU (3.1) (1.5) (9.7) (0.4) (3.0) (2.2)   
Sex (vaginal or anal) with a 2,023 323 1,037 595 18 50 <0.0001 0.0350 
MSM (1.1) (0.8) (2.2) (0.7) (1.0) (0.9)   
Any personal or partner risk 165,420 37,125 44,243 77,693 1,541 4,818 <0.0001 <0.0001 
 (89.9) (90.3) (92.3) (88.7) (87.9) (84.9)   
Previous HIV testing       <0.0001 <0.0001 
 
Yes 
 
139,854 
 
28,536 
 
34,703 
 
71,689 
 
1,132 
 
3,794 
  
 (76.0) (69.4) (72.4) (81.9) (64.6) (66.9)   
No 37,323 11,019 10,940 13,621 540 1,203   
 (20.3) (26.8) (22.8) (15.6) (30.8) (21.2)   
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Don’t Know/refused 6,860 1,562 2,283 2,259 81 675 
 (3.7) (3.8) (4.8) (2.6) (4.6) (11.9) 
 
STD = sexually transmitted disease; HIV = human immunodeficiency virus; IDU = injection drug user; MSM = man that has sex with men 
aChi-squared statistics were used to compare the variables (alpha = 0.05) 
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Table 3. Adjusted odds ratio estimates for partner risk and personal risk among women not pregnant and 
tested for HIV in Florida 2012, by race/ethnicity, foreign-born vs. US-born, and country of birth. 
 
 
Partner Risk ORa 
(95% CI) 
 
Personal Risk ORa 
(95% CI) 
 
Model 1 Independent variable race/ethnicity 
 
Non-Hispanic White Referent Referent 
 
Latina 
 
0.38 (0.35, 0.41) 
 
0.85 (0.80, 0.89) 
 
Non-Hispanic Black 
 
0.18 (0.17, 0.20) 
 
0.71 (0.68, 0.75) 
 
Other 
 
0.41 (0.32, 0.52) 
 
0.69 (0.59, 0.81) 
 
Missing 
 
0.43 (0.37, 0.50) 
 
0.56 (0.51, 0.61) 
 
Model 2 Independent variable US vs. foreign birth 
 
US-born Referent Referent 
 
Foreign-born 
 
0.46 (0.40, 0.54) 
 
0.98 (0.89, 1.08) 
 
missing 
 
0.77 (0.62, 0.95) 
 
1.00 (0.86, 1.16) 
 
Model 3 Independent variable country of birth 
 
US Referent Referent 
 
Mexico 
 
0.21 (0.15, 0.29) 
 
1.31 (1.13, 1.52) 
 
Cuba 
 
0.50 (0.38, 0.66) 
 
0.98 (0.85, 1.14) 
 
Guatemala 
 
0.07 (0.03, 0.23) 
 
0.92 (0.73, 1.15) 
 
Honduras 
 
0.37 (0.24, 0.56) 
 
1.07 (0.88, 1.31) 
 
Colombia 
 
0.39 (0.28, 0.55) 
 
0.90 (0.77, 1.06) 
 
Puerto Rico 
 
0.99 (0.78, 1.25) 
 
0.85 (0.72, 1.01) 
 
Nicaragua 
 
0.37 (0.22, 0.62) 
 
0.87 (0.69, 1.09) 
 
El Salvador 
 
0.35 (0.17, 0.69) 
 
1.23 (0.89, 1.68) 
 
Dominican Republic 
 
0.48 (0.31, 0.75) 
 
0.80 (0.65, 0.99) 
 
Peru 
 
0.38 (0.23, 0.65) 
 
0.99 (0.78, 1.26) 
 
Venezuela 
 
0.29 (0.15, 0.55) 
 
0.80 (0.63, 1.02) 
 
Brazil 
 
0.71 (0.40, 1.26) 
 
1.05 (0.71, 1.53) 
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Other South America 0.52 (0.34, 0.79) 1.08 (0.87, 1.36) 
 
Other Central America 
 
0.72 (0.40, 1.28) 
 
1.26 (0.86, 1.86) 
 
Other non-Latino countries 
 
0.52 (0.26, 1.05) 
 
0.95 (0.63, 1.43) 
 
Missing 
 
0.71 (0.58, 0.88) 
 
0.99 (0.86, 1.14) 
a Odds ratios adjusted for age 
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Table 4. HIV risk behaviors, previous HIV testing and demographics by US-Born and Foreign-Born 
Latinas who were not pregnant at time of testing 
 
 
 
Country of Birth US-born 
n (%) 
Foreign-born 
n (%) 
Missing 
n (%) 
US-born 
vs. 
Foreign- 
born 
p-valuea 
Foreign- 
born vs. 
Missing 
p-valuea 
Total n = 9333 n = 25363 n = 6421   
Mean Age (years) 29.0 35.0 26.7   
Age Group (n)    <0.0001 <0.0001 
13-19 1614 (17.3) 1353 (5.3) 1412 (22.0)   
20-29 4671 (50.1) 8241 (32.5) 3130 (48.8)   
30-39 1690 (18.1) 7876 (31.1) 1182 (18.4)   
40-49 930 (10.0) 4628 (18.3) 480 (7.5)   
50 and over 428 (4.6) 3265 (12.9) 217 (3.4)   
Any personal risk (n) 8331 (89.3) 22799 (89.9) 5958 (92.8) 0.0882 <0.0001 
Sex (vaginal or anal) with a 
male 
8273 (88.6) 22778 (89.8) 5931 (92.4) 0.0017 <00001 
Sex for drugs/money/other 
items (anal, vaginal or oral) 
407 (4.4) 174 (0.7) 164 (2.6) <0.0001 <0.0001 
STD diagnosis 725 (7.8) 758 (3.0) 488 (7.6) <0.0001 <0.0001 
Injection drug use 353 (3.8) 105 (0.4) 108 (1.7) <0.0001 <0.0001 
Any partner risk (n) 618 (6.6) 442 (1.7) 216 (3.4) <0.0001 <0.0001 
Sex (vaginal or anal) with 
HIV-positive person 
155 (1.7) 223 (0.9) 56 (0.9) <0.0001 0.9566 
Sex (vaginal or anal) with an 
IDU 
369 (4.0) 142 (0.6) 124 (1.9) <0.0001 <0.0001 
Sex (vaginal or anal) with a 
MSM 
152 (1.6) 112 (0.4) 59 (0.9) <0.0001 <0.0001 
Any personal or partner risk 
(n) 
8355 (89.5) 22808 (89.9) 5962 (92.9) 0.2684 <0.0001 
Previous HIV testing (n)    <0.0001 <0.0001 
Yes 6526 (70.3) 17484 (68.9) 4526 (70.5)   
No 2583 (27.7) 6875 (27.1) 1561 (24.3)   
Don’t Know/Refused 296 (2.7) 932 (4.0) 334 (5.2)   
a Chi squared statistics were used to compare the variables (alpha = 0.05) 
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STD = sexually transmitted disease, HIV = human immunodeficiency virus, IDU = injection drug user, 
MSM = man that has sex with men 
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Table 5: HIV risk behaviors, previous HIV testing and demographics by Country of Birth among Latina women who are not pregnant at the time of 
testing 
Latina Country of Birth USa 
n (%) 
Meb 
n (%) 
Cuc 
n (%) 
Cod 
n (%) 
Gue 
n (%) 
Hof 
n (%) 
PRg 
n (%) 
Nih 
n (%) 
ESi 
n (%) 
 
Total (n) 
 
9,333 
 
6,540 
 
3,944 
 
2,241 
 
1,826 
 
1,916 
 
1,794 
 
1,052 
 
898 
 
Mean Age (years) 
 
27.9 
 
32.5 
 
36.9 
 
39.5 
 
31.4 
 
34.6 
 
34.7 
 
37.8 
 
32.8 
 
Age Group 
13-19 1,614 
(17.3) 
322 
(4.9) 
273 
(6.9) 
117 
(5.2) 
46 
(2.5) 
69 
(3.6) 
160 
(8.9) 
25 
(2.3) 
35 
(3.9) 
20-29 4,671 
(50.1) 
2,346 
(35.9) 
1,188 
(30.1) 
527 
(23.5) 
839 
(46.0) 
655 
(34.2) 
565 
(31.5) 
269 
(25.6) 
333 
(37.1) 
30-39 1,690 
(18.1) 
2,569 
(39.3) 
818 
(20.7) 
484 
(21.6) 
684 
(37.5) 
673 
(35.1) 
471 
(26.3) 
328 
(31.2) 
348 
(38.8) 
40-49 930 
(10.0) 
994 
(15.2) 
893 
(22.6) 
523 
(23.3) 
184 
(10.1) 
288 
(15.0) 
366 
(20.4) 
240 
(22.8) 
126 
(14.0) 
50 and over 428 
(4.6) 
309 
(4.7) 
772 
(19.6) 
603 
(26.2) 
73 
(4.0) 
231 
(12.1) 
232 
(12.9) 
190 
(18.1) 
56 
(6.2) 
Any personal risk 8,331 
(89.3) 
6,118 
(93.6) 
3,471 
(88.0) 
1,907 
(85.1) 
1,699 
(93.0) 
1,755 
(91.6) 
1,559 
(86.9) 
930 
(88.4) 
841 
(93.7) 
Sex (vaginal or anal) with a 
male 
8,273 
(88.6) 
6,115 
(93.5) 
3,467 
(87.9) 
1,906 
(85.1) 
1,698 
(93.0) 
1,753 
(91.5) 
1,558 
(86.9) 
929 
(88.3) 
840 
(93.5) 
Sex for drugs, money, or other 
items (anal, vaginal, or oral) 
407 
(4.4) 
11 
(0.2) 
46 
(1.2) 
9 
(0.4) 
9 
(0.5) 
11 
(0.6) 
39 
(2.2) 
5 
(0.5) 
2 
(0.2) 
STD diagnosis 725 
(7.8) 
141 
(2.2) 
122 
(3.1) 
55 
(2.5) 
40 
(2.2) 
58 
(3.0) 
75 
(4.2) 
41 
(3.9) 
20 
(2.2) 
Injection drug use 353 
(3.8) 
6 
(0.1) 
23 
(0.6) 
7 
(0.3) 
2 
(0.1) 
3 
(0.2) 
33 
(1.8) 
3 
(0.3) 
2 
(0.2) 
Any partner risk 618 
(6.6) 
50 
(0.8) 
78 
(2.0) 
40 
(1.8) 
4 
(0.2) 
25 
(1.3) 
105 
(5.9) 
16 
(1.5) 
9 
(1.0) 
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Sex  (vaginal  or  anal)  with 
HIV-positive person 
155 
(1.7) 
20 
(0.3) 
42 
(1.1) 
21 
(0.9) 
3 
(0.2) 
20 
(1.0) 
47 
(2.6) 
11 
(1.1) 
5 
(0.6) 
Sex (vaginal or anal) with an 
IDU 
369 
(4.0) 
12 
(0.2) 
20 
(0.5) 
9 
(0.4) 
0 
(0.0) 
4 
(0.2) 
58 
(3.2) 
3 
(0.3) 
4 
(0.5) 
Sex (vaginal or anal) with a 
MSM 
152 
(1.6) 
19 
(0.3) 
21 
(0.5) 
10 
(0.5) 
1 
(0.1) 
2 
(0.1) 
16 
(0.9) 
2 
(0.2) 
2 
(0.2) 
Any  personal  or  partner 
risk 
8,355 
(89.5) 
6,118 
(93.6) 
3,473 
(88.1) 
1,910 
(85.2) 
1,699 
(93.0) 
1,755 
(91.6) 
1,560 
(87.0) 
930 
(88.4) 
841 
(93.7) 
Previous HIV testing 
Yes 6,526 
(69.9) 
4,785 
(73.2) 
2,400 
(60.9) 
1,447 
(64.6) 
1,199 
(65.7) 
1,375 
(71.8) 
1,294 
(72.1) 
705 
(67.0) 
660 
(73.5) 
No 2,583 
(27.7) 
1,549 
(23.7) 
1,350 
(34.2) 
712 
(31.8) 
538 
(29.5) 
467 
(24.4) 
428 
(23.9) 
300 
(28.5) 
198 
(22.1) 
Don’t Know/Refused 224 
(2.4) 
206 
(3.2) 
194 
(4.9) 
82 
(3.7) 
89 
(4.9) 
74 
(3.9) 
72 
(4.0) 
47 
(4.5) 
40 
(4.5) 
Latina Country of Birth DRj 
n (%) 
Pek 
n (%) 
Vel 
n (%) 
Brazil 
n (%) 
OSAm 
n (%) 
OCAn 
n (%) 
Othero 
n (%) 
Missingp 
n (%) 
p-value 
Total (n) 898 1,075 887 799 394 1,104 367 291 6,656 
 
Mean Age (years) 
 
32.8 
 
35.8 
 
36.8 
 
35.9 
 
34.8 
 
36.8 
 
36.2 
 
32.9 
 
26.9 
 
Age Group 
13-19 35 
(3.9) 
61 
(5.7) 
50 
(5.6) 
43 
(5.4) 
17 
(4.3) 
76 
(6.9) 
14 
(3.8) 
25 
(8.6) 
1,432 
(21.5) 
20-29 333 
(37.1) 
357 
(33.2) 
243 
(27.4) 
238 
(29.8) 
124 
(31.5) 
253 
(22.9) 
109 
(29.7) 
108 
(37.1) 
3,217 
(48.3) 
30-39 348 
(38.8) 
262 
(24.4) 
251 
(28.3) 
236 
(29.5) 
141 
(35.8) 
355 
(32.2) 
111 
(30.3) 
78 
(26.8) 
1,249 
(18.8) 
40-49 126 
(14.0) 
200 
(18.6) 
189 
(21.3) 
158 
(19.8) 
69 
(17.5) 
239 
(21.7) 
72 
(19.6) 
50 
(17.2) 
517 
(7.8) 
50 and over 56 
(6.2) 
195 
(18.1) 
154 
(17.4) 
124 
(15.5) 
43 
(10.9) 
181 
(16.4) 
61 
(16.6) 
30 
(10.3) 
241 
(3.6) 
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Any personal risk 841 
(93.7) 
930 
(88.4) 
783 
(88.3) 
689 
(86.2) 
359 
(91.1) 
981 
(88.9) 
333 
(90.7) 
259 
(89.0) 
6,143 
(92.3) 
Sex (vaginal or anal) with a 
male 
840 
(93.5) 
930 
(86.5) 
782 
(88.2) 
688 
(86.1) 
358 
(90.9) 
978 
(88.6) 
333 
(90.7) 
259 
(89.0) 
6,115 
(91.9) 
Sex for drugs, money, or other 
items (anal, vaginal, or oral) 
2 
(0.2) 
5 
(0.5) 
8 
(0.9) 
9 
(1.1) 
3 
(0.8) 
10 
(0.9) 
4 
(1.1) 
1 
(0.3) 
166 
(2.5) 
STD diagnosis 20 
(2.2) 
35 
(3.3) 
38 
(4.3) 
32 
(4.0) 
17 
(4.3) 
39 
(3.5) 
19 
(5.2) 
18 
(6.2) 
496 
(7.5) 
Injection drug use 2 
(0.2) 
0 
(0.0) 
7 
(0.8) 
3 
(0.4) 
2 
(0.5) 
9 
(0.8) 
1 
(0.3) 
3 
(1.0) 
109 
(1.6) 
Any partner risk 9 
(1.0) 
22 
(2.1) 
15 
(1.7) 
10 
(1.3) 
13 
(3.3) 
25 
(2.3) 
13 
(3.5) 
9 
(3.1) 
224 
(3.4) 
Sex  (vaginal  or  anal)  with 
HIV-positive person 
5 
(0.6) 
13 
(1.2) 
6 
(0.7) 
6 
(0.8) 
4 
(1.0) 
14 
(1.3) 
6 
(1.6) 
3 
(1.0) 
590 
(0.9) 
Sex (vaginal or anal) with an 
IDU 
4 
(0.5) 
5 
(0.5) 
6 
(0.7) 
1 
(0.1) 
1 
(0.3) 
9 
(0.8) 
3 
(0.8) 
4 
(1.4) 
127 
(1.9) 
Sex (vaginal or anal) with a 
MSM 
2 
(0.2) 
6 
(0.6) 
6 
(0.7) 
3 
(0.4) 
8 
(2.0) 
6 
(0.5) 
6 
(1.6) 
2 
(0.7) 
61 
(0.9) 
Any  personal  or  partner 
risk 
841 
(93.7) 
932 
(86.7) 
783 
(88.3) 
689 
(86.2) 
359 
(91.1) 
981 
(88.9) 
334 
(91.0) 
259 
(89.0) 
6,147 
(92.4) 
Previous HIV testing 
Yes 660 
(73.5) 
782 
(72.7) 
603 
(68.0) 
567 
(71.0) 
296 
(75.1) 
736 
(66.7) 
283 
(77.1) 
215 
(73.9) 
4,663 
(70.1) 
No 198 
(22.1) 
259 
(24.1) 
252 
(28.4) 
209 
(26.2) 
82 
(20.8) 
322 
(29.2) 
76 
(20.7) 
67 
(23.0) 
1,627 
(24.4) 
Don’t Know/Refused 40 
(4.5) 
34 
(3.2) 
32 
(3.6) 
23 
(2.9) 
16 
(4.1) 
46 
(4.2) 
8 
(2.2) 
9 
(3.1) 
366 
(5.5) 
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STD = sexually transmitted disease, HIV = human immunodeficiency virus, IDU = injection drug user, MSM = man that has sex with men 
a US: United States and territories excluding Puerto Rico 
b Me: Mexico 
c Cu: Cuba 
d Co: Colombia 
e Gu: Guatemala 
f Ho: Honduras 
g PR: Puerto Rico 
h Ni: Nicaragua 
i ES: El Salvador 
j DR: Dominican Republic 
k Pe: Peru 
l Ve: Venezuela 
m OSA: other South America  
n OCA: other Central America 
o Other: other country of birth 
p Missing: country of birth not documented 
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Abstract 
 
 
Introduction:  Latina women in the United States (US) are not only disproportionately 
affected by human immunodeficiency virus (HIV) infection, but also underutilize HIV 
prevention services, such as HIV testing. Methods: HIV testing events were examined 
to describe the HIV testing behaviors and test results among Latinas tested in 2012 at 
publicly funded sites in Florida, US. Multivariable logistic regression was used to assess 
the demographic characteristics associated with reports of previous testing and positive 
HIV test results. Results:  Of the 184,037 testing events, 87,569 (45.6%) were among 
non-Hispanic Blacks (NHBs), 47,926 (26.0%) non-Hispanic Whites (NHWs), 41,117 
(22.3%) Latinas, 5,672 (3.1%) those with unknown race/ethnicity, and 1,753 (1.0%) other 
racial/ethnic groups. Compared to NHW and NHB women, Latinas testing for HIV were 
older (mean age 32.1, NHW mean age 30.3, NHB mean age 30.0; p<0.0001). Results 
indicated that women who reported previous HIV testing had decreased odds of being 
Latina (adjusted odds ratio [AOR] 0.90; 95% confidence interval [CI] 0.87, 0.94). 
Conclusion: These findings indicate that Latinas are underutilizing HIV testing, and 
efforts are needed to increase the proportion of Latinas, especially younger Latinas, tested 
for HIV in Florida. 
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Introduction 
 
 
The demographics of the HIV epidemic in the US have changed over the years; 
HIV infection now affects more women and members of ethnic/racial minority 
populations than in previous years (Institute of Medicine, 2001; CDC, 2016a). Although 
Latinos make up approximately 17% of the US population, they make up about 24% of 
all new HIV infection diagnoses (United States Census Bureau, 2015; CDC, 2016a). In 
2014, the incidence of HIV among Latino men was more than triple the rate among non- 
Hispanic white (NHW) men (37.4 cases per 100,000 vs. 10.8 cases per 100,000), and 
rates between Latina women and NHW women demonstrates a similar disparity (5.3 
cases per 100,000 vs. 1.6 cases per 100,000) (CDC, 2016a). Given these incidence rates, 
it is particularly important that Latinas be tested for HIV infection. 
 
The CDC recommends that all individuals, aged 13–64 years of age, be screened 
on an “opt out” basis (consent is inferred unless the patient declines testing) for HIV 
infection at all health care settings as part of routine medical care. Persons at high-risk for 
HIV infection should be screened at least once annually (CDC, 2006). Both the CDC’s 
Guide for HIV Testing in Nonclinical Settings and Revised Guidelines for HIV 
Counseling, Testing, and Referral also emphasize the importance of early knowledge of 
HIV status and increasing the accessibility and availability of HIV testing services (CDC, 
2016b; CDC, 2001).  HIV testing is the central step in both the HIV prevention 
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continuum and HIV care continuum, which collectively create a framework for 
monitoring and evaluating HIV program performance (The White House Office of the 
Press Secretary, 2013; McNairy & El-Sadr, 2014). HIV testing also creates opportunities 
to link HIV-positive and HIV-negative people into appropriate care and prevention 
services. For an HIV-positive person, this means linkage to medical care, appropriate 
antiretroviral therapy (ARV), and prevention services leading to a suppressed viral load 
and lower probability of transmitting HIV to sex partners (CDC, 2001; CDC, 2011a; 
Hall, Walker, Shah & Belle, 2012; Marks et al., 2005). 
 
Despite the CDC report that HIV testing rates have increased from 2000 to 2010 
(CDC, 2013a), the National HIV Behavioral Surveillance data indicate that only 60.7% 
of Latinos report ever having tested for HIV compared to 70.2% among NHWs and 80% 
among NHBs (CDC, 2015a). Additionally, Latinos with HIV infection are more likely to 
be tested late in their HIV infection compared with NHWs (CDC, 2013b; CDC, 2003; 
Chen, Gallant & Page, 2012; Sheehan, Trepka & Dillion, 2014). Early testing can 
improve HIV-related outcomes along the HIV care continuum including linkage to care, 
retention in care, and viral load suppression (CDC, 2013b; Gant et al., 2014). 
 
In 2011, Florida had the highest number of publicly funded testing events of all 
states, accounting for 12% of all CDC-funded HIV testing events (CDC, 2013c). 
However, a study of people diagnosed with HIV in Florida between 2007–2011 identified 
that Latinos were more likely to be diagnosed late with HIV infection (defined as an 
AIDS diagnosis within 3 months of an HIV diagnosis) than NHWs in urban areas, where 
the vast majority of HIV infections in Florida occur (Trepka et al., 2014).  Furthermore, 
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in Florida, the proportion of newly reported HIV infections among Latinas increased 
from 15% in 2005 to 17% in 2014, and Latinas continue to be at higher risk (12 cases per 
100,000) of acquiring HIV compared with NHW women (5.4 cases per 100,000) (Florida 
Department of Health, 2014; Florida Department of Health, 2013a). The objective of this 
study was to compare HIV testing behaviors and outcomes between Latina women and 
women in other racial/ethnic groups tested at publicly funded sites in Florida, a state with 
a diverse Latina community, in order to determine if HIV testing activities are reaching 
the populations disproportionately affected by HIV. 
 
Methods 
 
 
 
 
Study design and population 
 
This cross-sectional study used de-identified data from the Florida HIV 
Counseling and Testing Database, which included demographic and risk behavior 
information from all records of women tested for HIV in publicly-funded HIV counseling 
and testing sites in Florida, totaling 209,954 records. These data were recorded by trained 
counselors, who collected demographic and risk behavior information from persons 
voluntarily testing for HIV on the Department of Health 1628 Testing and Counseling 
Forms. The variables captured included self-reported risk behaviors during the 12 months 
prior to testing, race, ethnicity, gender, previous HIV testing, and current testing site.  
This information was sent to the Florida Department of Health Counseling, Testing and 
Linkage data team, and entered into a database. HIV test results were then additionally 
included as they became available. Records of women who responded “yes” to current 
pregnancy (24,836) were excluded from the analysis because these HIV tests may have 
44  
been driven by routine obstetric testing as opposed to testing because of perceived risk of 
HIV infection. Records from transgender individuals were excluded from the sample 
because of small numbers (59 Latina, 57 NHW, 120 NHB, 3 belonging to other 
race/ethnicity, and 3 had unknown race/ethnicity). Records with missing gender 
information were also excluded (833). The final dataset for the current study included 
184,037 publicly-funded HIV testing events for women, 13 years of age and older, in the 
state of Florida during 2012. 
 
The dataset was of testing events; therefore, it was possible that some women 
were tested more than once in the given year, resulting in being represented more than 
once in the dataset. However, because the records were de-identified, it was not possible 
to exclude records for women that tested more than once in 2012. 
 
Classification of variables 
 
 
All variables were categorical except for age, which was recoded into age groups: 
13–19, 20–29, 30–39, 40–49 and 50 years and older. Risk factors were categorized as 
either personal or partner risk. Personal risk was defined as any factor that would place an 
individual at-risk for HIV based on their own risk behaviors or activities, and partner risk 
was defined as having vaginal or anal sex with a partner with increased risk of HIV.  A 
woman was considered to have personal risk if she responded “yes” to any of the 
following within the past 12 months: vaginal/anal sex with a male, anal/vaginal/oral sex 
for drugs/money/other items, diagnosis of sexually transmitted disease (STD), or 
injection drug use. “Yes” responses to having vaginal or anal sex with an HIV-positive 
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person, an injection drug user (IDU), or a man that has sex with men (MSM) in the past 
12 months were considered partner risk (Taveras et al., 2016). 
 
Statistical analysis 
 
 
Descriptive statistics were first performed including age, race/ethnicity, foreign- 
born versus US-born status, previous HIV testing, and HIV test result. Mean ages were 
compared using independent sample t-test and analysis of variance. Chi-square tests for 
categorical variables were performed to identify significant differences in age groups, 
previous HIV testing and HIV test result by race/ethnicity. 
 
Controlling for age, two multivariable analyses were conducted. The first model 
included previous HIV testing as the dependent variable. To examine differences in 
previous HIV testing events among women publicly tested for HIV in Florida, adjusted 
odds ratio (AOR) and 95% confidence intervals (CIs) were calculated by analyzing HIV 
testing: 1) by race/ethnicity and 2) by personal and partner risk. The second model 
included HIV positivity as the dependent variable which was analyzed three different 
ways: 1) by race/ethnicity, 2) by personal and partner risk, and 3) by previous testing. In 
addition to personal and partner risk categories, each risk behavior was analyzed 
separately (see classification of variables in the above section). Clustering effects of 
testing site were handled through a random intercept using SAS Proc Glimmix. SAS 
software, version 9.3 (SAS Institute, Cary, NC 2002) was used to conduct all analyses. 
The [Blinded for review] and [Blinded for review] Institutional Review Boards (IRB) 
deemed this study non-human subjects research. 
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Results 
 
 
Sample characteristics 
 
 
Of the 184,037 testing events included in these analyses, 47.6% were among 
NHB, 26.0% were among NHW, 22.3% were among Latinas, 3.1% had no recorded 
race/ethnicity (unknown), and 1.0% belonged to “other” race/ethnicity (Table 1). Of the 
testing events, 43.0% were among US born women, 23.2% were among foreign-born, 
and 33.9% were missing ‘country of birth’ information. The majority of testing events 
among Latinas (61.7%) and more than one-quarter (26.1%) among NHB women were 
foreign-born. The mean age of women for whom HIV testing events were reported was 
30.5 years.  Among Latina women, the average age for the reported testing events was 
higher (mean age 32.1 years) than events among NHW and NHB women (NHW mean 
age 30.3 years, p<0.0001; NHB mean age 30.0 years, p<0.0001). The majority of the 
testing events (76.0%) were among women who had previous HIV testing; 20.3% were 
among those with no previous testing; and for 3.7% it was not known if the woman had 
previously tested for HIV. Previous HIV testing was less frequently reported among 
records of Latinas than NHW and NHB women (69.4% vs. 72.4%, p<0.0001 and 69.4% 
vs. 81.9%, p<0.0001 respectively) (Table 1). 
 
Previous HIV testing patterns by demographic characteristics and risk behaviors 
 
 
Testing event records of women with previous HIV testing reported more 
personal and partner risk than records of women with no previous testing (personal risk 
91.3% vs. 85.0%, p<0.0001; partner risk 5.3% vs. 3.4%, p<0.0001) (Table 2).  In 
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multivariable analysis, after controlling for age, testing events among Latina women 
demonstrated lower odds and events among NHB women higher odds of previous HIV 
testing compared with events among NHW women (Latina AOR 0.90, 95% CI: 0.87- 
0.94; NHB AOR 1.85, 95% CI: 1.79-1.91) (Table 3). Testing events among women who 
reported any risk (personal or partner) had higher odds of previous HIV testing than 
testing events among women not reporting risk (personal risk AOR 1.62, 95% CI: 1.56, 
1.68 and partner risk AOR 1.36, 95% CI: 1.28, 1.44 respectively). 
 
 
HIV test results by demographic characteristics and previous HIV testing 
 
 
Among the records of women tested, 0.5% had a positive HIV test result, and 
0.1% had an indeterminate test result or were missing confirmatory results (Table 1). The 
highest percentage of records with a positive HIV test result was among NHBs (0.7%) 
followed by NHWs (0.3%) and Latinas (0.3%). The mean age was 39.2 years for women 
with records that documented a positive HIV test result and 30.5 years for records that 
documented an HIV-negative test result. However, the difference was not statistically 
significant (Table 4). After controlling for age, testing events among NHB women and 
women with unknown race/ethnicity were more likely to result in HIV-positive outcomes 
than testing events of NHW women (NHB AOR 2.42, 95% CI: 1.98, 2.96; unknown 
race/ethnicity AOR 1.81, 95% CI: 1.19, 2.75 respectively) (Table 3). 
 
HIV test results by risk behaviors 
 
 
Personal risk was less likely to be reported in the records that had an HIV-positive 
result compared to records documenting an HIV-negative test result (79.4% versus 
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89.8%, p<0.0001) (Table 4). However, in examining specific personal risks, records of 
women with an HIV-positive test result were significantly more likely to include for 
drugs/money/other items relative to records of women with an HIV-negative result (8.0% 
versus 3.6%, p<0.0001) or injection drug use (4.4% versus 3.1%, p = 0.0260). Partner 
risk was significantly more likely to be included in records documenting an HIV-positive 
test result than records documenting a negative HIV test result (15.4% versus 4.9%, 
p<0.0001); significant differences were specifically found in records of women engaging 
in vaginal or anal sex with an HIV-positive person (11.4% versus 1.1%, p<0.0001) 
(Table 4).  In the multivariable analysis, after controlling for age and race/ethnicity, 
testing events with reports of personal risk were less likely to have an HIV-positive test 
result than testing events without personal risk (AOR 0.51, 95% CI: 0.43, 0.61) (Table 3). 
The testing records that included reports of partner risk had greater odds of documenting 
a positive test result than records without partner risk (AOR 3.86, 95% CI: 3.13, 4.76). 
 
Discussion 
 
 
Latinas had a similar representation among testing event data (22.3%) as their 
proportion of the adult female population in Florida (21.9%).  However, younger Latinas, 
specifically the 13–19 and 20–29 year age groups, were under-represented among the 
HIV testing events (Florida Department of Health, n.d.). The average age among Latinas 
in the HIV testing event records was older than that for other racial/ethnic groups, 
suggesting that Latinas may be accessing HIV testing services, and consequently, 
additional prevention services (along the HIV prevention and care continuums) at a later 
age than other races/ethnicities. Records of Latinas testing for HIV indicated that most 
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were foreign-born. The older age of Latinas at the time of testing could be explained by 
the impact of acculturation onto HIV testing, or it is possible that younger Latinas are not 
aware of HIV risk, resulting in delays in HIV testing (Kinsler et al., 2009). 
For Latinas, there may be additional reasons why previous HIV testing was not 
reported, such as a lack of awareness or misunderstanding around partner risk, HIV 
stigma, barriers accessing medical care, and insufficient effective prevention strategies 
and initiatives for Latinas, especially ones targeting younger Latinas and those foreign- 
born (Vega, Klukas, Valera & Montenegro, 2015; Cianelli et al., 2010; Wohl, Tejero & 
Frye, 2009). Self-reported HIV risk behaviors, particularly partner risk, among Latinas in 
Florida vary by country of birth (Taveras et al., 2016). A greater understanding of partner 
risk among Latinas may increase perceived HIV susceptibility and HIV testing behaviors 
in this population (Cianelli et al., 2010). There may be a correlation between frequency of 
HIV testing and the perceived susceptibility and report of HIV risk. However, this 
information was not captured in the HIV counseling and testing forms. 
More than three quarters (76%) of the testing events were for women with 
previous HIV testing which was associated with increased report of risk behaviors, 
alluding to some adherence to CDC’s HIV testing recommendations (CDC, 2006). 
However, testing events among Latinas were less likely to include previous HIV testing 
compared to records for NHW and NHB women, which is consistent with the national 
data (CDC, 2015a). These results suggest that testing among Latinas is suboptimal given 
that Latina women are more than three times as likely to be infected with HIV as NHW 
women (CDC, 2016). This may be the result of the robust effort to target NHB women in 
the state of Florida, which has not been addressed in a comparable capacity for Latinas 
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(Florida Department of Health HIV/AIDS Section, n.d.a; Florida Department of Health 
HIV/AIDS Section, n.d.b). HIV testing messages and services targeted to MSM and 
black communities may be less effective among Latinas, especially young Latinas. 
Current prevention strategies and initiatives for Latinas in Florida are scarce, and 
evaluation data on what does exist are limited (Florida Department of Health HIV/AIDS 
Section, n.d.a; Florida Department of Health HIV/AIDS Section, n.d.b). In addition, the 
promotion of routine testing should focus on all women, including young Latinas, in 
order to encourage greater awareness of their HIV status and regular HIV testing, in 
accordance with current CDC HIV testing recommendations (CDC, 2006; CDC, 2001). 
Latinos are the fastest growing minority population in the US. They are also 
culturally diverse and differ in national origin, mode of HIV transmission, HIV 
behavioral risk factors, perception of risk, use of prevention services, and timeliness of 
HIV testing (CDC, 2015b; CDC, 2007; Espinoza et al., 2007; Garcia, Betancourt & 
Scaccaborrozzi, 2015). The diversity among Latinos should be considered in the planning 
of effective HIV prevention, care and treatment programs, and ongoing data should be 
collected to evaluate the effectiveness of programming for this target population (Gant et 
al., 2014; Garcia, Betancourt & Scaccaborrozzi, 2015). HIV testing is a critical step in the 
HIV prevention continuum, the HIV care continuum, and in the provision of appropriate 
and effective prevention care and treatment services to populations disproportionately 
affected by HIV (McNairy & El-Sadr, 2014). Enhancing HIV testing services may result 
in better addressing the three primary goals of the National HIV/AIDS Strategy: 1) 
reducing the number of people who become infected with HIV; 2) increasing access to 
care and improving health outcomes for people living with HIV; and 3) reducing HIV- 
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related health disparities (The White House Office of the Press Secretary, 2013; Gant et 
al., 2014; CDC, 2011b; Sionean et al., 2014; Office of National AIDS Policy, 2010; 
Office of National AIDS Policy, 2015). 
 
HIV testing is considered a High Impact Prevention (HIP) activity by the CDC 
(CDC, 2011b).  In the current study, testing event records of women with previous HIV 
testing included significantly more risk behaviors compared to testing event records of 
women without previous HIV testing suggesting that previous testing encounters did not 
result in lower levels of risk behavior. Current HIV testing and counseling strategies, 
especially for those testing negative, may not be effective at reducing HIV risk, and 
therefore, a continued need exists to develop innovative and culturally appropriate risk 
reduction strategies to prevent new HIV infections (CDC, 2013b; Gant et al., 2014; CDC, 
2013c; Sionean et al., 2014; Craig et al., 2012).  The rationale for HIV testing suggests 
that previous testing should increase awareness of perceived risk and the need to test for 
HIV regularly (Ebrahim, Anderson, Weidle & Purcell, 2004). 
 
Finally, the collection of data from the large number of people testing in publicly 
funded HIV testing sites represents an opportunity to collect information about 
prevention efforts.  For example, a history of exposure to previous primary HIV 
prevention activities (i.e. use of Pre Exposure Prophylaxis [PrEP] and referral and receipt 
of HIV prevention services) is not captured but could be captured in the HIV testing 
database. Additional information about factors affecting health disparities such as 
psychosocial service needs addressing intimate partner violence, mental health and 
substance abuse treatment would also be useful (CDC, Health Resources and Services 
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Administration, National Institutes of Health, American Academy of HIV Medicine, 
Association of Nurses in AIDS Care, International Association of Providers of AIDS 
Care, the National Minority AIDS Council, and Urban Coalition for HIV/AIDS 
Prevention Services, 2014). Recommendations for HIV prevention with adults and 
adolescents with HIV in the United States, 2014; CDC, 2015c; Stallworth et al., 2009). 
The CDC continues to encourage state and local health departments to establish protocols 
to ensure high quality data (CDC, 2006; CDC, 2013c; CDC, Health Resources and 
Services Administration, National Institutes of Health, American Academy of HIV 
Medicine, Association of Nurses in AIDS Care, International Association of Providers of 
AIDS Care, the National Minority AIDS Council, and Urban Coalition for HIV/AIDS 
Prevention Services, 2014). Enhancing the HIV testing process and the data collected 
could facilitate the monitoring and evaluation of HIV program performance while 
addressing indicators of both the HIV prevention and care continuums. 
 
This study had several limitations. First, the dataset only included information on 
HIV testing conducted at publicly funded HIV testing sites. There may be differences in 
the women testing in private versus public HIV testing locations because public HIV 
testing requires no insurance. Thus, results may not be generalizable to the private 
setting.  Second, previous HIV testing and HIV risk behaviors were self-reported. Social 
desirability bias has been found to cause an underreporting of undesirable behaviors such 
as HIV risk behaviors and an increase in reporting favorable behaviors such as HIV 
testing (Sionean et al., 2014). It is also likely that some women were unaware of risk 
behaviors among partners and thus may have underreported partner risk.  Important 
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behaviors such as engagement in prevention services and consistent condom use are not 
captured in the testing database. Third, country of birth was missing for a notable 
number of records of Latina women and even more so for NHW women, limiting the 
analysis that could be conducted to determine variations in testing behaviors and 
positivity among foreign-born and US-born women. Estimates for HIV incidence could 
not be determined utilizing this dataset because positivity included both previous and 
newly identified HIV positive individuals; of testing events among Latinas with an HIV 
positive test result, almost half (48.9%) previously tested positive (Florida Department of 
Health, 2013b). Finally, as indicated in our methods section, pregnant women were 
excluded from this analysis due to concerns about referral bias; thus, the reported risk and 
demographic profile represents non-pregnant Latinas. 
 
Conclusions 
 
 
Florida remains disproportionately affected by HIV, with the second highest rate 
of newly diagnosed HIV infections and third highest number of adults (age 13+) living 
with a diagnosis of HIV infection through the end of 2015 in the United States (CDC, 
2016a). The current study suggests that Latinas, especially younger Latinas, are 
underutilizing HIV testing services. There is a critical need to increase strategies and 
initiatives targeted to Latinas, including those addressing partner risk, in order to increase 
the proportion of Latinas tested for HIV in Florida and the numbers of young Latinas 
accessing additional prevention services. In addition, culturally competent, effective risk 
reduction activities need to be integral components of the HIV testing process. Testing 
and counseling data could prove to be very valuable in the evaluation of HIV testing 
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services provided to Latinos in the State of Florida. It is important to have established 
monitoring and evaluation practices, such as regular examination of counseling and 
testing data, to appropriately measure prevention effectiveness and consequently progress 
toward the goals of the National HIV/AIDS Strategy (CDC, 2006; Sionean et al., 2014). 
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Table 1: Previous HIV testing and positivity by race/ethnicity among non-pregnant women tested for HIV in Florida 2012 
 
 
Race/ethnicity Total Latina 
n (%) 
NHW 
n (%) 
NHB 
n (%) 
Other 
n (%) 
Missing 
n (%) 
Latina 
vs. NHW 
p-valuea 
Latina 
vs. NHB 
p-valuea 
Total n (%) 184,037 41,117 (22.3) 47,926 (26.0) 87,569 (47.6) 1,753 (1.0) 5,672 (3.1)   
Mean age (standard 
deviation) 
30.5 32.1 (11.6) 30.3 (13.0) 30.0 (11.4) 30.9 (11.5) 30.1 (11.6) <0.0001 <0.0001 
Age group (years)       <0.0001 <0.0001 
13-19 24,522 (13.3) 4,379 (10.7) 6,974 (14.6) 12,084 (13.8) 202 (11.5) 883 (15.6)   
20-29 81,231 (44.1) 16,042 (39.0) 21,103 (44.0) 40,811 (46.6) 791 (45.1) 2,484(43.8)   
30-39 39,605 (21.5) 10,748 (26.1) 9,698 (20.2) 17,590 (20.1) 379 (21.6) 1,190 (21.0)   
40-49 23,158 (11.5) 6,038 (14.7) 6,182 (12.9) 10,048 (11.5) 234 (13.4) 647 (11.4)   
50 and over 15,530 (8.4) 3,910 (9.5) 3,969 (8.3) 7,036 (8.0) 147 (8.4) 468 (8.3)   
Country of birth       <0.0001 <0.0001 
US-born 79,116 (43.0) 9,333 (22.7) 19,640 (41.0) 47,979 (54.8) 435 (24.8) 1,729 (30.5)   
Foreign-born 42,605 (23.2) 25,363 (61.7) 2,528 (5.3) 12,534 (26.1) 805 (45.9) 1,375 (24.2)   
Missing 62,316 (33.9) 6,421 (15.6) 25,758 (53.8) 27,056 (30.9) 513 (29.3) 2,568 (45.3)   
Previous HIV testing       <0.0001 <0.0001 
Yes 139,854 (76.0) 28,536 (69.4) 34,703 (72.4) 71,689 (81.9) 1,132 (64.6) 3,794 (66.9)   
No 37,323 (20.3) 11,019 (26.8) 10,940 (22.8) 13,621 (15.6) 540 (30.8) 1,203 (21.2)   
Don’t Know/refused 6,860 (3.7) 1,562 (3.8) 2,283 (4.8) 2,259 (2.6) 81 (4.6) 675 (11.9)   
Positivity       0.323 <0.0001 
No 182,985 (99.4) 40,969 (99.6) 47,771 (99.7) 86,858 (99.2) 1,749 (99.8) 5,638 (99.4)   
Yes 928 (0.5) 125 (0.3) 138 (0.3) 630 (0.7) 4 (0.2) 31 (0.6)   
Indeterminate/missingb 124 (0.1) 23 (0.1) 17 (0.0) 81 (0.1) 0 (0.0) 3 (0.1)   
NHB = Non-Hispanic Black, NHW = Non-Hispanic White 
aChi-squared statistics were used to compare the variables. The statistical significance level alpha was set to 0.05. 
bIndeterminate/missing HIV tests without a confirmatory result 
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Table 2. HIV risk behaviors and demographics by previous HIV testing among non-pregnant women tested for HIV in Florida 2012 
 
 Previous HIV 
testing 
n (%) 
No Previous HIV 
testing 
n (%) 
Not Sure of 
Previous HIV 
testing 
n (%) 
p-valuea 
(α = 0.05) 
Total n (%) 139,854 (76.0) 37,323 (20.3) 6,680 (3.7)  
Mean age (standard deviation) 31.0 (10.7) 28.7 (13.7) 31.7 (12.5) 0.2747 
Age group (years)    < .0001 
13-19 12,284 (8.8) 11,331 (30.4) 907 (13.2)  
20-29 64,716 (46.3) 13,726 (36.8) 2,789 (40.7)  
30-39 33,804 (24.2) 4,348 (11.7) 1,453 (21.2)  
40-49 18,691 (13.4) 3,529 (9.5) 929 (13.5)  
50 and over 10,359 (7.4) 4,389 (11.8) 782 (11.4)  
Any personal risk 127,671 (91.3) 31,709 (85.0) 5,814 (84.8) < .0001 
Sex (vaginal or anal) with a male 127,109 (90.9) 31,591 (84.6) 5,786 (84.3) < .0001 
Sex for drugs/money/other items (anal, 
vaginal or oral) 
5,630 (4.0) 692 (1.9) 257 (3.8) < .0001 
STD diagnosis 11,589 (8.3) 1,612 (4.3) 415 (6.1) < .0001 
Injection drug use 4,661 (3.3) 775 (2.1) 353 (5.2) < .0001 
Any partner risk 7,414 (5.3) 1,266 (3.4) 450 (6.6) < .0001 
Sex (vaginal or anal) with HIV-positive 
person 
1,826 (1.3) 235 (0.6) 40 (0.6) < .0001 
Sex (vaginal or anal) with an IDU 4,625 (3.3) 794 (2.1) 376 (5.5) < .0001 
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Sex (vaginal or anal) with a MSM 1,650 (1.2) 315 (0.8) 58 (0.9) < .0001 
Any personal or partner risk 127,848 (91.4) 31,749 (85.1) 5,823 (84.9) < .0001 
Positivity    < .0001 
No 138,983 (99.4) 37,194 (99.7) 6,808 (99.2)  
Yes 761 (0.5) 121 (0.3) 46 (0.7)  
Indeterminate/ Missingb 110 (0.1) 8 (0.0) 6 (0.1)  
STD = sexually transmitted disease, HIV = human immunodeficiency virus, IDU = injection drug user, MSM = man that has sex with men 
aChi-squared statistics were used to compare the variables. 
bIndeterminate/missing HIV tests without a confirmatory result. 
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Table 3. Adjusted odds ratio estimates for previous HIV testing and positive HIV test result among non-pregnant women tested for HIV in Florida 2012 
 
Previous HIV testing OR 
(95% CI) 
HIV Positivity OR (95%CI) 
 
Model 1a Independent variable race/ethnicity 
Latina 0.90 (0.87, 0.94) 0.88 (0.68, 1.15) 
 
Non-Hispanic Black 1.85 (1.79, 1.91) 2.42 (1.98, 2.96) 
 
Other 0.73 (0.65, 0.81) 0.74 (0.27, 2.03) 
 
Missing 1.20 (1.11, 1.29) 1.81 (1.19, 2.75) 
 
Non-Hispanic White Referent Referent 
 
Model 2b Independent variable ‘personal risk’ and ‘partner risk’ 
Any personal risk 1.62 (1.56, 1.68) 0.51 (0.43, 0.61) 
 
No personal risk Referent Referent 
 
Any partner risk 1.36 (1.28, 1.44) 3.86 (3.13, 4.76) 
 
No partner risk Referent Referent 
 
Model 3b Independent variable previous HIV testing 
 
Previous HIV testing n/a Referent 
 
No previous HIV testing n/a 0.93 (0.78, 1.10) 
 
a Odds ratios adjusted for age 
b Odds ratios adjusted for age and race/ethnicity 
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Table 4. HIV risk behaviors and demographics by HIV test result among women non-pregnant and tested 
for HIV in Florida 2012 
 
Positive HIV Test 
n (%) 
Negative HIV Test 
n (%) 
p-valuea 
(α = 0.05) 
 
Total n (%) 
 
928 
 
182,985  
Mean age in years 
(standard deviation) 
39.2 (11.7) 30.5 (11.5) 0.2236 
Age group (years)   < 0.0001 
13-19 28 (3.0) 24,486 (13.4)  
20-29 189 (20.4) 81,015 (44.3)  
30-39 261 (28.1) 39,310 (21.5)  
40-49 252 (27.2) 22,867 (12.5)  
50 and over 198 (21.3) 15,307 (8.4)  
Race/ethnicity   < 0.0001 
Latina 125 (13.5) 40,969 (22.4)  
Non-Hispanic White 138 (14.9) 47,771 (26.1)  
Non-Hispanic Black 630 (67.9) 86,858 (47.5)  
Other 4 (0.4) 1,749 (1.0)  
Missing 31 (3.3) 5,638 (3.1)  
Any personal risk 737 (79.4) 164,356 (89.8) < 0.0001 
Sex (vaginal or anal) with 
a male 
727 (78.3) 163,660 (89.4) < 0.0001 
Sex for drugs/money/other 
items (anal, vaginal or 
oral) 
74 (8.0) 6,494 (3.6) < 0.0001 
STD diagnosis 61 (6.6) 13,543 (7.4) 0.3365 
Injection drug use 41 (4.4) 5,744 (3.1) 0.0260 
Any partner risk 143 (15.4) 8,973 (4.9) < 0.0001 
Sex (vaginal or anal) with 
HIV-positive person 
106 (11.4) 1,986 (1.1) < 0.0001 
Sex (vaginal or anal) with 
an IDU 
37 (4.0) 5,752 (3.1) 0.1421 
Sex (vaginal or anal) with 
a MSM 
11 (1.2) 2,009 (1.1) 0.7988 
Any personal or partner 
risk 
738 (79.5) 164,581 (89.9) < 0.0001 
Previous HIV testing   < 0.0001 
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Yes 
 
761 (82.0) 
 
138,983 (76.0) 
No 121 (13.0) 37,194 (20.3) 
Don’t know/refused 46 (5.0) 6,808 (3.7) 
 
STD: sexually transmitted disease; HIV: human immunodeficiency virus; IDU: injection drug user; MSM: 
man that has sex with men 
a Chi-squared statistics were used to compare the variables. 
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MANUSCRIPT 3 
 
 
 
Abstract 
 
 
Objective: Over the years the number of perinatal infections in the United States (US) 
has continued to decline, but the prevalence of female adults and adolescents living with 
diagnosed HIV infection has continued to rise. Therefore, opportunities still exist to 
prevent mother-to child HIV transmission. The purpose of this study was to identify 
demographics, reported HIV risk behaviors, and testing behaviors among pregnant 
women tested at publicly funded sites in Florida, and to compare these characteristics by 
HIV testing site type. Methods: Multivariable analyses were conducted to examine 
demographics, HIV risk and testing behaviors among records of pregnant women 
publicly tested for HIV in Florida. Results: The testing records indicated that Latina and 
non-Hispanic black (NHB) women had decreased odds of reporting partner risk 
compared to those from non-Hispanic white (NHW) women (Latina: adjusted odds ratio 
[AOR] 0.20, 95% confidence interval [CI]: 0.14-0.28; and NHB: AOR 0.14, 95% CI: 
0.10-0.21), and women tested in prisons/jails had higher odds of reporting previous HIV 
testing compared to prenatal care sites (AOR 1.86, 95% CI: 1.03-3.39). Conclusion: An 
understanding of HIV risk and testing behaviors among pregnant women by site type can 
be used to enhance current testing and prevention strategies targeted to pregnant women 
and facilitate timely linkage to care. 
 
 
 
KEYWORDS: HIV testing, human immunodeficiency virus, pregnant women, perinatal, 
mother-to-child transmission 
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Introduction 
 
 
 
Over the years the number of perinatal infections in the United States has 
continued to decline (188 in 2010 and 86 in 2015), but the prevalence of female adults 
and adolescents living with diagnosed HIV infection continues to rise (163.8 per 100,000 
in 2010 and 171.0 per 100,000 in 2015) (Centers for Disease Control and Prevention 
[CDC], 2016a). It is estimated that 8,500 women living with HIV give birth every year 
(CDC, 2016b). As there continue to be HIV-positive women of childbearing age, it is 
important to continue robust HIV prevention efforts for this population (Nesheim et al., 
2012). Even with decreased rates of mother-to-child transmission, studies demonstrate 
that opportunities to prevent transmission still exist by enhancing HIV testing, care and 
treatment of HIV-infected pregnant women and understanding birth trends and patterns 
of care among these women (Trepka et al., 2017; Moyer, 2013; Sansom et al., 2007; 
McKenna & Hu, 2007; Nesheim et al., 2012). HIV testing and the early identification of 
HIV infection of pregnant women through universal prenatal screening is an important 
component of successful prevention of mother-to-child transmission of HIV (Nesheim et 
al., 2012). The most recent recommendations for the HIV screening of pregnant women 
emphasize that HIV testing should be part of routine prenatal care (CDC, 2001). 
In 1988, Florida was one of the first states, with high rates of reported HIV 
infection cases, to authorize comprehensive legislation addressing HIV/AIDS (Florida 
Department of Health [FDOH], 2013a). This authorization was done through the 
enactment of the Omnibus AIDS Act which aimed to promote patient-initiated HIV 
testing through informed consent and ensured confidentiality. However, pregnancy is an 
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exception to this legal requirement for written informed consent. Since 2005, the Florida 
law was amended and aligned with CDC recommendations for HIV screening on an “opt 
out” basis (consent is inferred unless the patient declines testing) at all health care 
settings as part of routine medical care (CDC, 2006; FDOH, 2013a). Additional 
requirements in Florida mandate repeat HIV testing at 28-32 weeks of gestation (FDOH, 
2013a). Of the 2,444 pediatric HIV cases reported in Florida, through 2014, 95% were 
perinatally acquired. The most common mode of HIV exposure for mothers of infants, 
who were perinatally infected and were born in Florida between 1994 and 2014 was 
heterosexual contact followed by mother’s risk not specified and injection drug use (69%, 
16% and 14% respectively; FDOH, 2015). Of the HIV-positive mothers who gave birth 
in Florida between 2007 and 2014, 57% knew their HIV status prior to pregnancy, 16% 
during pregnancy, 7% at delivery and 19% after birth (FDOH 2015). Even with much 
information and progress addressing perinatal transmission in the US, studies and 
information examining HIV testing site types among pregnant women are limited at best, 
and reports on publicly funded HIV testing do not focus on pregnant women (CDC 2015, 
FDOH, 2013b, Lawrence, Liu & Towner, 2009). There is a need to explore and 
understand patterns of and reasons for receipt of HIV testing among pregnant women by 
site type, which can be used to improve current prevention strategies targeted to pregnant 
women. 
The purpose of this study was to identify reported HIV risk behaviors, testing 
behaviors and demographics among pregnant women tested at publicly funded sites in 
Florida, and to compare these characteristics by HIV testing site type. 
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Methods 
 
 
Study design and population 
 
This cross-sectional study used de-identified data from the Florida HIV 
Counseling and Testing Database, which included demographic and risk behavior 
information from all records of women, 13 years of age and older, tested for HIV in 
publicly-funded HIV counseling and testing sites in Florida, during 2012, totaling 
209,954 records. These data were recorded by trained counselors, who collected 
demographic and risk behavior information from persons voluntarily testing for HIV on 
the Department of Health 1628 Testing and Counseling Forms. The captured variables 
included self-reported risk behaviors during the 12 months prior to testing, race, 
ethnicity, gender, previous HIV testing, and current testing site. This information was 
sent to the Florida Department of Health Counseling, Testing and Linkage Data Team, 
and entered into a database. HIV test results were then additionally included as they 
became available. Records from transgender individuals were excluded from the sample 
because of small numbers (59 Latina, 57 NHW, 120 NHB, three belonging to other 
race/ethnicity, and three had unknown race/ethnicity). Records with missing gender 
information were also excluded (833). Records of women who responded “yes” to 
current pregnancy (24,836) were selected and included in the final dataset for analysis. 
 
The dataset was of testing events; therefore, it was possible that some women 
were tested more than once in the given year, resulting in them being represented more 
than once in the dataset. However, because the records were de-identified, it was not 
possible to exclude records for women who tested more than once in 2012. 
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Classification of variables 
 
 
All variables were categorical except for age, which was recoded into age groups: 
13–19, 20–29, 30–39, 40–49 and 50 years and older. Risk factors were categorized as 
either personal or partner risk. Personal risk was defined as any factor that would place an 
individual at risk for HIV based on their own risk behaviors or activities, and partner risk 
was defined as having vaginal or anal sex with a partner with increased risk of HIV. A 
woman was considered to have personal risk if she responded “yes” to any of the 
following within the past 12 months: anal/vaginal/oral sex for drugs/money/other items, 
diagnosis of sexually transmitted disease (STD), or injection drug use. “Yes” responses to 
having vaginal or anal sex with an HIV-positive person, an injection drug user (IDU), or 
a man who has sex with men (MSM) in the past 12 months were considered partner risk 
(Taveras et al., 2016). Vaginal/anal sex with a male was excluded from personal risk and 
examined independently because it is expected that among women reporting currently 
being pregnant, most would also report vaginal/anal sex with a male. HIV testing site 
types were categorized as prenatal care sites (prenatal/obstetrics [OB] and family 
planning), STD clinic sites, drug treatment facilities, prison/jail, other non-healthcare,  
and other healthcare. Other non-health care sites included anonymous HIV testing sites, 
community-based organizations, county health department field visits, and special 
projects. Other healthcare sites included tuberculosis clinics, adult health clinics, 
college/university HIV testing sites, and private/medical doctor [MD] clinics. 
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Data analysis 
 
 
Descriptive analyses were first performed of demographic characteristics, reported 
risks, history of previous HIV testing, and HIV test results. Mean ages were compared 
using independent samples t-tests and analyses of variance. Chi-square tests for 
categorical variables were performed to identify significant differences in US-born vs. 
foreign-born, personal risk reported and previous HIV testing by race/ethnicity. Fisher’s 
exact tests were conducted to identify significant differences among categorical variables 
that had cell sizes <5. 
 
Controlling for age, three multivariable analyses were conducted; the dependent 
variables for each were personal risk, partner risk and previous testing. To examine 
differences among pregnant women publicly tested for HIV in Florida, adjusted odds 
ratio (AOR) and 95% confidence intervals (CIs) were calculated by analyzing dependent 
variables: 1) by race/ethnicity, 2) nativity (US-born vs. foreign-born), 3) site type, and 4) 
previous HIV testing. Clustering effects of testing site were handled through a random 
intercept using SAS Proc Glimmix. SAS software, version 9.3 (SAS Institute, Cary, NC 
2002) was used to conduct all analyses. The Florida Department of Health and Florida 
International University Institutional Review Boards (IRB) deemed this study non-human 
subjects research. 
 
Results 
Sample characteristics 
Of the 24,836 testing events included in these analyses, 41.1% were among 
Latinas, 27.4% were among NHB, 26.7% were among NHW, 2.7% had no recorded 
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race/ethnicity (missing), and 2.1% belonged to “other” race/ethnicity (Table 1). The mean 
age among records of pregnant women was 26.5 years (standard deviation 6.3) and was 
higher among records from Latinas (mean age 27.2 years) than from NHW and NHB 
women (NHW mean age 25.6 years, p<0.0001; NHB mean age 26.2 years, p<0.0001). 
Fewer than half of the testing events (45.8%) were among foreign-born women, 14.3% 
were among US born, and 33.9% were missing ‘country of birth’ information. Three- 
quarters of testing events among Latinas, and more than one-third among NHB women 
were for foreign-born women (75.2% and 34.0% respectively). Most testing events 
(98.4%) reported vaginal or anal sex with a male in the prior 12 months, while only 7.2% 
reported any other personal or partner risk in the past 12 months. Report of previous STD 
diagnosis in the past 12 months (4.7%) was the most frequently reported risk followed by 
injection drug use (1.3%) and vaginal or anal sex with an injection drug user (1.3%). The 
majority of the testing events (81.7%) were among women who had previous HIV 
testing, 13.2% had no previous testing, and for 5.1% it was not known if previous testing 
for HIV had occurred (Table 1). 
 
Race/ethnicity among pregnant women with HIV testing 
 
 
Significant differences between racial/ethnic groups with respect to reported risks 
were identified in the bivariate analyses. Personal risk was more frequently reported 
among testing events from NHW women and NHB women than Latinas (9.6%, 9.1% and 
3.0% respectively NHW vs. Latina p<0.0001; NHB vs. Latina p<0.0001), and partner 
risk was significantly more frequently reported among NHW than Latina women (4.8% 
vs. 0.5%; p <0.0001) (Table 1). However, excluding vaginal/anal sex with a male, most 
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HIV risk factors were more frequently reported among records from NHW women than 
Latinas such as vaginal/anal/oral sex for drugs/money/other items (2.3% vs. 0.4%; p 
<0.0001), injection drug use (4.3% vs. 0.2%; p <0.0001), vaginal/anal sex with an HIV- 
positive person (0.4% vs. 0.1%; p =0.0009), vaginal/anal sex with an IDU (4.1% vs. 
0.3%; p <0.0001), and vaginal/anal sex with an MSM (0.5% vs. 0.1%; p < 0.0001). 
However, compared with NHB women, Latina women more frequently reported 
vaginal/anal sex with an IDU (0.3% vs. 0.1%; p =0.0400), but less frequently reported 
STD diagnosis (2.5% vs. 8.1%; p <0.0001) and vaginal/anal sex with an HIV-positive 
person (0.1% vs. 0.4%; p =0.0012). 
 
In multivariate analysis, when controlling for age, records from Latina and NHB 
women had decreased odds of reporting partner risk than records from NHW women 
(Latina: AOR 0.20, 95% CI: 0.14-0.28; and NHB: AOR 0.14, 95% CI: 0.10-0.21) (Table 
2). In addition, HIV testing records among Latinas had fewer documented HIV-positive 
test result than records among NHB women (0.1% vs. 0.4%; p <0.0001) and was the 
same for NHW women (0.1%) (Table 1). 
 
Demographics among HIV testing pregnant women by site type 
 
 
The majority of testing records of pregnant women were from prenatal care sites 
(76.9%) followed by other non-healthcare sites (12.1%), STD clinic (5.0%), other 
healthcare (3.1%), drug treatment facilities (1.7%), and prison/jails (1.1%) (Table 3). 
Events at STD clinic testing sites were among women with the youngest mean age (24.6 
years) and with 21.8% being in the 13–19 year age group. Drug treatment testing sites 
had the greatest percentage (70.7%) of women in the 20–29 year age group and other 
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non-health care sites had the highest percentage of women in the 30–39 year and 40–49 
year age group (29.1% and 3.8% respectively). The race/ethnicity and foreign-born vs. 
US-born distribution of women varied by HIV testing site with the largest proportion of 
women tested in prenatal care sites being Latina (45.6%), NHW at drug treatment sites 
more frequently (82.3%), and NHB at other healthcare sites (53.3%). HIV testing events 
from prison/jail and other healthcare sites were more frequently US-born (85.6% and 
59.4% respectively), and women who tested at prenatal care sites and other non- 
healthcare sites were more frequently foreign-born (51.6% and 47.8% respectively). 
HIV risk behaviors among pregnant woman by site type 
 
Reported risk behaviors varied by testing site type (personal risk p <0.0001 and 
partner risk p <0.0001) (Table 3). Drug treatment site records reported the highest 
percentage anal/vaginal/oral sex for drugs/money/other items (16.4%), injection drug use 
(31.9%), and vaginal/anal sex with an IDU (31.6%) followed by prison/jail sites (12.9%, 
12.9% and 10.7% respectively). STD clinic sites reported the highest percentage of STD 
diagnosis followed by prison/jail testing sites (17.2% and 10.0% respectively). Records 
from other healthcare sites reported the highest percentage vaginal/anal sex with an HIV- 
positive person (2.2%), and records from drug treatment sites reported the highest 
percentage vaginal/anal sex with an MSM (1.4%). In multivariate analysis, when 
controlling for age, the odds of reporting risk (personal and partner) were greater for all 
testing site types when compared to prenatal sites (Table 2). 
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Previous HIV testing behaviors and HIV positive test result 
 
 
Previous HIV testing was less frequently reported among records of NHW 
women than Latinas and NHB women (79.5% vs. 80.9%, p<0.0001 and 79.5% vs. 
86.2%, p<0.0001 respectively) (Table 1). In multivariable analysis, after controlling for 
age, NHB women were more likely to have reported previous HIV testing compared to 
NHW women (AOR 1.69, 95% CI: 1.52-1.88) (Table 2). Report of previous HIV testing 
and HIV positivity varied significantly by HIV testing site type. Most testing event 
records from prison/jail sites reported previous HIV testing (92.6%), followed by prenatal 
care site (82.7%) and STD clinics (81.5%) (Table 3). Testing event records from drug 
treatment sites and other non-healthcare sites had the lowest report of previous HIV 
testing (64.7% and 77.7%). HIV testing records from other healthcare and STD clinics 
had the highest frequency of HIV positive test results (0.9% and 0.6% respectively). In 
multivariable analysis, after controlling for age, only testing events from prison/jail sites 
had higher odds of reporting previous HIV testing compared to prenatal care sites (AOR 
1.86, 95% CI: 1.03-3.39) (Table 2). Testing records that report previous testing, 
compared to records that do not report previous testing, had decreased odds of reporting 
personal risk (AOR 0.53, 95% CI: 0.45-0.64). Of the 45 positive test results, 19 (42.2%) 
were among prenatal care sites but prenatal care sites had the lowest percentage of 
positive results (0.1%) among all testing sites (Table 3). 
 
Discussion 
 
 
HIV testing records among Latinas made up the largest proportion of HIV testing 
events (41%), which is greater than their respective adult female population in Florida 
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(21.9%) (Florida Department of Health, n.d.). More than three-quarters of these testing 
events among Latinas were foreign-born. Both personal and partner risk were frequently 
reported in the testing records of NHW women. But, previous STD diagnosis, a risk 
identified in more than one-third of mothers with perinatally exposed infants, was most 
commonly reported among NHB women (FDOH, 2014; Trepka at al., 2017). Compared 
to women in other racial/ethnic groups, Latinas in Florida reported the lowest percentage 
of women aged 18-44 with healthcare insurance coverage while NHW women had a 
much higher percentage (60.0% Latinas vs. 80.3% NHW) (Robbins et. al, 2014). This 
data could imply that pregnant Latinas, especially foreign-born, may be receiving testing 
at publicly funded HIV testing sites as part of routine prenatal care, and pregnant NHW 
and NHB women may be seeking testing based on other motivators such as partner or 
personal risk factors. 
 
The odds of reporting both personal and partner risk were greater among all site 
types compared to prenatal care sites. The less frequent report of partner risk may suggest 
that some women were unaware of their partners’ risk behaviors which could have 
resulted in underreporting partner risk. Perceived low risk and previous HIV testing 
before pregnancy have been identified as the main reasons for refusing an HIV test 
(Coleman et al., 2009; Lawrence, Liu & Towner, 2009). Adherence to the CDC 
guidelines for universal HIV testing among pregnant women would encourage HIV 
testing regardless of risk perception and allow for more timely documentation of HIV 
status among pregnant women and more effective linkage to HIV care (Tan et al. 2011). 
Medical care providers can serve as conduits to the promotion of these guidelines by 
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increasing women’s willingness to be testing and reducing stigma associated with HIV 
testing (Rothpletz-Puglia, 2012; Coleman et al., 2009; King & Pate, 2014). 
 
HIV testing records from prison/jail testing site type had the greatest odds of 
reporting previous HIV testing. This finding may suggest fluctuations, by site type, in 
adherence to CDC’s HIV testing recommendations which can affect the potential to 
identify HIV positive pregnant women (CDC, 2006). Prenatal care sites had more HIV 
testing events among Latinas, drug treatment sites among NHW, and other healthcare 
sites among NHB. Results from examining site type suggest that pregnant women were 
motivated to seek and receive HIV testing based on various reasons concerning HIV risk 
perception and/or comfort with testing location or provider (King & Pate, 2014; 
Rothpletz-Puglia et al., 2012; Coleman et al, 2009). The state of Florida is noted for 
implementing a comprehensive perinatal HIV prevention program, since 1994, that 
targets health care providers, HIV-positive pregnant women, and high-risk women. 
However, even with the most recent Pregnancy Risk Assessment Monitoring System 
indicating that Florida is achieving one of the highest HIV testing rates among pregnant 
women in the US, 12.1% of pregnant women in Florida were not tested in 2013 (FDOH, 
2014, FDOH, 2016). 
 
Behaviors that place pregnant women at risk for HIV are similar to those for 
STDs. In addition to HIV testing, pregnant women should also receive screenings for 
chlamydia, gonorrhea, hepatitis B, and syphilis at their initial prenatal care visit and at 
28-32 weeks of gestation, especially since STD cases have reached the highest numbers 
ever (Florida Senate Committee on Health Policy, 2007; CDC, 2016). Results also 
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revealed that records from those who report personal risk were less likely to report 
previous HIV testing, meaning they were more likely to be first time testers. This data 
highlights the importance of adherence to universal testing standards for pregnant women 
to potentially identify new HIV cases and prevent transmission (CDC, 2006; FDOH, 
2013). 
 
The strength of this study is that it provides estimates of HIV risk and testing 
behaviors among pregnant women publicly testing for HIV and describes HIV testing 
behaviors and demographics by site type. Several limitations should be noted concerning 
this study. First, the dataset only included information about HIV testing conducted at 
publicly funded HIV testing sites. There may be differences in the pregnant women 
receiving testing services in private versus public HIV testing locations because public 
HIV testing requires no medical insurance and may explain the large percentage of 
foreign-born pregnant Latinas accessing services. Therefore, results may not be 
generalizable to the private medical setting. Second, only self-reported previous HIV 
testing risk behaviors were documented in the testing records which could explain an 
underreporting of undesirable behaviors such as HIV risk behaviors and an increase in 
reporting favorable behaviors such as HIV testing due to social desirability bias (Sionean 
et al., 2014). Third, due to recommendations to test pregnant women during both the first 
and third trimester, it is likely that women may be represented multiple times in this 
dataset. De-duplication of these testing events was not possible due to the de-identified 
data set available for analysis. The data utilized in this dataset also does not provide a 
time of gestation to further examine adherence to perinatal HIV testing recommendations. 
Of the 45 HIV-positive pregnant women identified in this dataset, most reported being 
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previously tested for HIV; however, estimates for HIV incidence could not be determined 
utilizing this dataset because positivity included both previously and newly identified 
HIV positive individuals (Florida Department of Health, 2013b). 
 
Conclusions 
 
 
The results from the study provide evidence that pregnant women continue to 
have various risk factors that place them and their un-born children at significant risk of 
acquiring HIV. Identification of HIV infections, especially acute HIV infections, through 
routine HIV testing during both first and third trimesters will remain a necessary 
component for the elimination of mother to child transmission as long as there are cases 
of HIV among women of childbearing age (Trepka et al., 2017; Nesheim et al., 2012; 
CDC, 2006; Burr et al., 2007; Moyer, 2013). Even with the effectiveness of state and 
national policy on the increased implementation of perinatal HIV prevention 
interventions, the results of this study add to the existing literature about patterns of 
testing among pregnant women specific to the state of Florida (Sarnquist et al., 2007). 
This new information can be used to enhance existing strategies aimed at improving the 
prevention of mother to child transmission through the promotion of routine HIV testing 
and improving prenatal health care (Nesheim et al., 2012, Johnson et al., 2006). 
Florida remains disproportionately affected by HIV, with the second highest rate 
of newly diagnosed HIV infections among adults (age 13+) through the end of 2015 and 
third highest rate of adults living with HIV through the end of 2014 in the United States 
(CDC, 2016a). Examining HIV testing site types may reveal motives for HIV testing 
among pregnant women as variations in reported risk were noted. Variations in reported 
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risk by race/ethnicity were also identified. Prevention strategies targeted to pregnant 
women should be culturally competent and may need to differ based on race/ethnicity. 
When targeting providers in Florida, understanding site type differences and trends in 
testing behaviors among pregnant women by site type can be utilized to effectively 
develop and communicate HIV High Impact Prevention strategies (CDC, 2011). The 
regular evaluation of testing and counseling data could prove to be very valuable in the 
evaluation of HIV testing and prenatal care services provided to pregnant women in the 
State of Florida and assist in enhancing current strategies to eliminate mother to child 
transmission of HIV (Nesheim et al., 2012, CDC, 2006, Burr et al., 2007, Moyer, 2013). 
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Table 1. HIV risk behaviors, previous HIV testing and demographics by race/ethnicity for women pregnant at the time of testing 
Race/ethnicity Total Latina 
n (%) 
NHW 
n (%) 
NHB 
n (%) 
Other 
n (%) 
Missing 
n (%) 
Latina 
vs. NHW 
p-valuea 
Latina vs. 
NHB 
p-valuea 
Total 24,836 n = 10,199 
(41.1) 
n = 6,631 
(26.7) 
(n = 6,796) 
(27.4) 
(n = 528) 
(2.1) 
(n = 682) 
(2.7) 
  
 
Mean age (standard deviation) 
 
26.5 
(6.3) 
 
27.2 
(6.2) 
 
25.6 
(6.0) 
 
26.2 
(6.6) 
 
28.9 
(6.1) 
 
26.8 
(6.7) 
 
<0.0001 
 
<0.0001 
Age group (years)       <0.0001 <0.0001 
13-19 3,028 
(12.2) 
1,078 
(10.6) 
896 
(13.5) 
972 
(14.3) 
10 
(1.9) 
72 
(10.6) 
  
20-29 14,369 
(57.9) 
5,605 
(55.0) 
4,202 
(63.4) 
3,870 
(57.0) 
303 
(57.4) 
389 
(57.0) 
  
30-39 6,749 
(27.2) 
3,245 
(31.8) 
1,377 
(20.8) 
1,736 
(25.5) 
190 
(36.0) 
201 
(29.5) 
  
40-49 646 
(2.6) 
261 
(2.6) 
143 
(2.2) 
201 
(3.0) 
23 
(4.4) 
18 
(2.6) 
  
50 and over 44 
(0.2) 
10 
(0.1) 
13 
(0.2) 
17 
(0.3) 
2 
(0.4) 
2 
(0.3) 
  
Nativity       <0.0001 <0.0001 
 
US-born 
 
3,544 
(14.3) 
 
837 
(8.2) 
 
1,037 
(15.6) 
 
1,584 
(23.3) 
 
21 
(4.0) 
 
65 
(9.5) 
  
Foreign-born 11,384 
(45.8) 
7,669 
(75.2) 
664 
(10.0) 
2,313 
(34.0) 
407 
(77.1) 
331 
(48.5) 
  
Missing 9,908 
(39.9) 
1,693 
(16.6) 
4,930 
(74.4) 
2,899 
(42.7) 
100 
(18.9) 
286 
(41.9) 
  
Any personal risk 1,619 
  (6.5)   
308 
(3.0)   
638 
(9.6)   
619 
(9.1)   
17 
(3.2)   
37 
(5.4)   
<0.0001 <0.0001 
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Sex for drugs/money/other items 
(anal, vaginal or oral) 
269 
(1.1) 
41 
(0.4) 
151 
(2.3) 
69 
(1.0) 
2 
(0.4) 
6 
(0.9) 
<0.0001 <0.0001 
STD diagnosis 1,177 
(4.7) 
259 
(2.5) 
322 
(4.9) 
552 
(8.1) 
14 
(2.7) 
30 
(4.4) 
<0.0001 <0.0001 
Injection drug use 329 
(1.3) 
22 
(0.2) 
284 
(4.3) 
16 
(0.2) 
1 
(0.2) 
6 
(0.9) 
<0.0001 0.7897 
Any partner risk 428 
(1.7) 
51 
(0.5) 
318 
(4.8) 
48 
(0.7) 
2 
(0.4) 
9 
(1.3) 
<0.0001 0.0835 
Sex (vaginal or anal) with HIV- 
positive person 
66 
(0.3) 
13 
(0.1) 
25 
(0.4) 
25 
(0.4) 
1 
(0.2) 
2 
(0.3) 
0.0009 0.0012 
Sex (vaginal or anal) with an 
IDU 
319 
(1.3) 
29 
(0.3) 
273 
(4.1) 
9 
(0.1) 
2 
(0.4) 
6 
(0.9) 
<0.0001 0.0400 
Sex (vaginal or anal) with a 
MSM 
68 
(0.3) 
14 
(0.1) 
36 
(0.5) 
16 
(0.2) 
0 
(0.0) 
2 
(0.3) 
<0.0001 0.1353 
Any personal or partner risk 1,790 
(7.2) 
334 
(3.3) 
747 
(11.3) 
650 
(9.6) 
18 
(3.4) 
41 
(6.0) 
  
Previous HIV testing       <0.0001 <0.0001 
Yes 20,281 
(81.7) 
8,248 
(80.9) 
5,269 
(79.5) 
5,861 
(86.2) 
373 
(70.6) 
530 
(77.7) 
  
No 3,284 
(13.2) 
1,461 
(14.3) 
921 
(13.9) 
689 
(10.4) 
113 
(21.4) 
100 
(14.7) 
  
Don’t Know/refused 1,271 
(5.1) 
490 
(4.8) 
441 
(6.7) 
246 
(3.6) 
42 
(8.0) 
52 
(7.6) 
  
Positivity       0.1532 <0.0001 
Yes 45 
(0.2) 
7 
(0.07) 
9 
(0.1) 
28 
(0.4) 
0 
(0.0) 
1 
(0.2) 
  
No 24,783 
(99.8) 
10,186 
(99.9) 
6,621 
(99.9) 
6,767 
(99.6) 
528 
(100.0) 
681 
(99.9) 
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Indeterminate/missingb 8 6 1 1 0 0 
  (0.03) (0.06) (0.02) (0.01) (0.0) (0.0)   
 
 
NHB = Non-Hispanic Black, NHW = Non-Hispanic White, STD = sexually transmitted disease, HIV = human immunodeficiency virus, IDU = injection 
drug user, MSM = man that has sex with men 
a Chi-squared statistics were used to compare the variables. The statistical significance level alpha was set to 0.05 
b Indeterminate/missing HIV tests without a confirmatory result 
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Table 2. Adjusted odds ratio estimates for previous HIV testing among women tested for HIV in Florida 2012, by reported pregnancy at time of testing 
 
Personal Risk ORa 
(95% CI) 
Partner Risk ORa 
(95% CI) 
Previous Testing ORa 
(95% CI) 
 
Model 1 Independent variable race/ethnicity 
 
Non-Hispanic White Referent Referent Referent 
 
 
Latina 0.47 (0.40, 0.55) 0.20 (0.14, 0.28) 1.09 (0.99, 1.19) 
Non-Hispanic Black 1.17 (1.01, 1.35) 0.14 (0.10, 0.21) 1.69 (1.52, 1.88) 
 
Other 
 
0.54 (0.33, 0.90) 
 
0.14 (0.03, 0.59) 
 
0.50 (0.41, 0.62) 
 
Missing 
 
0.76 (0.53, 1.10) 
 
0.49 (0.24, 1.03) 
 
0.91 (0.74, 1.12) 
 
Model 2b Independent variable nativity 
 
US-born 
 
Foreign-born 
Referent 
 
0.27 (0.22, 0.35) 
Referent 
 
0.18 (0.10, 0.34) 
Referent 
 
0.65 (0.55, 0.76) 
 
Missing 
 
0.75 (0.60, 0.93) 
 
0.79 (0.48, 1.30) 
 
0.76 (0.64, 0.90) 
 
Model 3b Independent variable site type 
Prenatal care Referent Referent Referent 
 
STD clinic 
 
5.25 (3.58, 7.68) 
 
5.65 (2.56, 12.46) 
 
1.09 (0.77, 1.55) 
 
Drug treatment 
 
9.49 (5.29, 17.03) 
 
34.74 (13.79, 87.49) 
 
1.04 (0.58, 1.88) 
 
Prison/jail 
 
7.78 (4.60, 13.16) 
 
34.53 (14.73, 80.97) 
 
1.86 (1.03, 3.39) 
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Other non-healthcare 
 
 
2.50 (1.80, 3.49) 
 
 
16.17 (8.87, 29.45) 
 
 
0.95 (0.72, 1.26) 
 
Other healthcare 
 
2.00 (1.28, 3.14) 
 
12.66 (5.94, 27.00) 
 
0.73 (0.51, 1.04) 
 
Model 4b Independent variable previous HIV testing 
 
No previous HIV testing Referent Referent n/a 
 
Previous HIV testing 0.53 (0.45, 0.64) 1.38 (0.97, 1.96) n/a 
 
 
OR = odds ratio, CI = confidence interval, STD = sexually transmitted disease, HIV = human immunodeficiency virus, US = United States 
a Odds ratios adjusted for age 
b Odds ratios adjusted for age and race/ethnicity 
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Table 3. HIV risk behaviors, previous testing and positivity of Latinas reporting currently pregnant at time of testing by testing site type 
Site Type STD Clinic 
n (%) 
Drug 
Treatment 
n (%) 
Prison/Jail 
n (%) 
Prenatal 
Care 
n (%) 
Other non- 
healthcare 
n (%) 
Other 
healthcare 
n (%) 
p-valuea 
Total n = 1,245 
(5.0) 
n = 433 
(1.7) 
n = 271 
(1.1) 
n = 19,115 
(76.9) 
n = 3,007 
(12.1) 
n = 765 
(3.1) 
 
 
Mean age (standard deviation) 
 
24.6 (6.1) 
 
26.9 (5.1) 
 
26.4 (6.2) 
 
26.6 (6.1) 
 
26.9 (6.8) 
 
26.6 (8.3)  
Age group (years)       <0.0001 
13-19 272 (21.8) 13 (3.0) 23 (8.5) 2,241 (11.7) 369 (12.3) 110 (14.4)  
20-29 729 (58.6) 306 (70.7) 181 (66.8) 11,061 (57.9) 1,639 (54.5) 453 (59.2)  
30-39 216 (17.4) 109 (25.2) 58 (21.4) 5,336 (27.9) 874 (29.1) 156 (20.4)  
40-49 27 (2.2) 4 (0.9) 6 (2.2) 470 (2.5) 113 (3.8) 26 (3.4)  
50 and over 1 (0.1) 1 (0.2) 3 (1.1) 7 (0.0) 12 (0.4) 20 (2.6)  
Race/ethnicity       <0.0001 
Latina 223 (18.3) 18 (4.2) 49 (18.2) 8,593 (45.6) 1,111 (37.5) 205 (27.2)  
NHW 521 (42.7) 353 (82.3) 115 (42.8) 5,172 (27.4) 352 (11.9) 118 (15.6)  
NHB 451 (37.0) 53 (12.4) 104 (38.7) 4,362 (23.2) 1,424 (48.1) 402 (53.3)  
Other 16 (1.3) 1 (0.2) 1 (0.4) 447 (2.4) 45 (1.5) 18 (2.4)  
Missing 9 (0.7) 4 (0.9) 0 (0.0) 272 (1.4) 31 (1.1) 12 (1.6)  
Nativity       <0.0001 
US-born 607 (48.8) 79 (18.2) 232 (85.6) 594 (3.1) 1,195 (39.7) 454 (59.4)  
Foreign-born 218 (17.5) 5 (1.2) 8 (3.0) 9,871 (51.6) 1,437 (47.8) 228 (29.8)  
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missing 420 (33.7) 349 (80.6) 31 (11.4) 8,650 (45.3) 375 (12.5) 83 (10.9)  
Any personal risk 242 (19.4) 180 (41.6) 78 (28.8) 816 (4.3) 231 (7.7) 72 (9.4) <0.0001 
Sex for drugs/money/other items 
(anal, vaginal or oral) 
21 (1.7) 71 (16.4) 35 (12.9) 64 (0.3) 65 (2.2) 13 (1.7) <0.0001 
STD diagnosis 214 (17.2) 24 (5.5) 27 (10.0) 700 (3.7) 157 (5.2) 55 (7.2) <0.0001 
Injection drug use 19 (1.5) 138 (31.9) 35 (12.9) 85 (0.4) 40 (1.3) 12 (1.6) <0.0001 
Any partner risk 26 (2.1) 141 (32.6) 33 (12.2) 121 (0.6) 82 (2.7) 25 (3.3) <0.0001 
Sex (vaginal or anal) with HIV- 
positive person 
7 (0.6) 1 (0.2) 3 (1.1) 8 (0.0) 30 (1.0) 17 (2.2) <0.0001 
Sex (vaginal or anal) with an IDU 15 (1.2) 137 (31.6) 29 (10.7) 93 (0.5) 37 (1.2) 8 (1.1) <0.0001 
Sex (vaginal or anal) with a MSM 6 (0.5) 6 (1.4) 2 (0.7) 29 (0.2) 22 (0.7) 3 (0.4) <0.0001 
Any personal or partner risk 252 (20.2) 205 (47.3) 87 (32.1) 879 (4.6) 278 (9.3) 89 (11.6) <0.0001 
Previous HIV testing       <0.0001 
Yes 1,014 (81.5) 280 (64.7) 251 (92.6) 15,800 (82.7) 2,335 (77.7) 601 (78.6)  
No 163 (13.1) 16 (3.7) 18 (6.6) 2,367 (12.4) 577 (19.2) 143 (18.7)  
Don’t Know/refused 68 (5.5) 137 (31.6) 2 (0.7) 948 (5.0) 95 (3.2) 21 (2.8)  
Positivity       <0.0001 
Yes 7 (0.6) 1 (0.2) 1 (0.4) 19 (0.1) 10 (0.3) 7 (0.9)  
No 1,238 (99.4) 432 (99.8) 268 (98.9) 19,093 (99.9) 2,995 (99.6) 757 (99.0)  
Indeterminate/missingb 2 (0.1) 0 (0.0) 2 (0.7) 3 (0.0) 0 (0.0) 1 (0.1)  
 
NHB = Non-Hispanic Black, NHW = Non-Hispanic White, STD = sexually transmitted disease, HIV = human immunodeficiency 
virus, IDU = injection drug user, MSM = man that has sex with men, US = United States 
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a Chi-square statistics were used to compare the variables. Fisher’s exact test was used for cell frequencies less than 5. The statistical significance 
level alpha was set to 0.05. 
b Indeterminate/missing HIV tests without a confirmatory result 
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CONCLUSIONS 
 
 
To our knowledge, this is the first study that utilized a large state-wide dataset, 
and that encompasses a diverse sample of Latinas, to identify HIV risk differences among 
Latinas by country of birth. Findings from this study demonstrate that reported risk 
behaviors varied by race/ethnicity, US-born versus foreign-born status, and by Latina 
country of origin. Based on this information, HIV prevention messages should be tailored 
for Latinas, taking into account cultural differences and nativity, to increase 
effectiveness. 
This study also indicates that Latinas are underutilizing HIV testing services, and 
efforts are needed to increase the proportion of Latinas, especially younger Latinas, who 
should get tested for HIV in Florida. The less frequent self-reporting of partner risk 
reveals that attention should be given to the topic of partner risk and susceptibility to 
HIV. Furthermore, results from the study provide evidence that pregnant women continue 
to have various risk factors that place them and their un-born children at significant risk 
of acquiring HIV. Identification of HIV infections, especially acute HIV infections, 
through routine HIV testing during both first and third trimesters will remain a necessary 
component for the elimination of mother-to-child transmission as long as there are cases 
of HIV among women of childbearing age. 
The regular evaluation of testing and counseling data could prove to be of 
considerable value in the appraisal of effective HIV prevention, HIV testing, and care 
services provided to women in the State of Florida and assist in enhancing current 
strategies to reduce transmission of HIV. It is important to have established monitoring 
94  
and evaluation practices, such as regular examination of counseling and testing data, to 
appropriately measure prevention effectiveness and subsequently progress toward the 
goals of the National HIV/AIDS Strategy. Future studies should further examine the 
concept of partner behaviors as it relates to culture and HIV risk among Latinas. The 
collection of risk and prevention behavior data should be incorporated as part of all HIV 
testing, regardless of funding source and routinely analyzed to enhance HIV programing 
and evaluation. 
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